Atrial septal defect, secundum type

Q17_ATRIAL_SEPTAL_DEFECT_SECUNDUM_TYPE

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — Q21.10 Hospital discharge: ICD-9 — 7455A Hospital discharge: ICD-8 — 74642 Cause of death: ICD-10 — Q21.10 Cause of death: ICD-9 — 7455A Cause of death: ICD-8 — 74642 2 out of 7 registries used, show all original rules.	1104
4. Check minimum number of events None	1104
5. Include endpoints None	1104
6. Filter based on genotype QC (FinnGen only)	1058

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

NAME	Q17_ATRIAL_SEPTAL_DEFECT_SECUNDUM_TYPE
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	Q2110
HD_ICD_9	7455A
HD_ICD_8	74642
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	Q2110
COD_ICD_9	7455A
COD_ICD_8	74642
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Atrial septal defect, secundum type based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

No upset plot: unknown.

No upset table: unknown.

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	1058	707	351
Unadjusted period prevalence (%)	0.22	0.25	0.16
Median age at first event (years)	21.27	22.69	18.41

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
1104: Matched controls
11001

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

Z871, ,

ICD-O-3

+∞

321.7

293

A02BC05, ,

ATC

esomeprazole; systemic

+∞

317.1

289

J01EE02, ,

ATC

sulfadiazine and trimethoprim; systemic

+∞

309.0

282

SPAT1310, ,

ICD-O-3

+∞

309.0

282

S01XA20, ,

ATC

artificial tears and other indifferent preparations; ophthalmic

+∞

309.0

282

J01FA10, ,

ATC

azithromycin; systemic

+∞

307.7

582

D82, ,

ICD-O-3

+∞

307.7

346

R05, ,

ICD-O-3

+∞

307.7

299

SPAT1325, ,

ICD-O-3

+∞

307.7

324

ZXD10, ,

ICD-O-3

+∞

307.7

478

R03AC02, ,

ATC

salbutamol; inhalant

+∞

307.7

558

WX408, ,

ICD-O-3

+∞

307.7

387

SDA03, ,

ICD-O-3

+∞

307.7

326

SDA02, ,

ICD-O-3

+∞

307.7

325

WX290, ,

ICD-O-3

+∞

307.7

421

FM1AE, ,

ICD-O-3

+∞

307.7

410

SAA01, ,

ICD-O-3

+∞

307.7

734

SAA03, ,

ICD-O-3

+∞

307.7

460

SPAT1256, ,

ICD-O-3

+∞

307.7

343

Z3231, ,

ICD-O-3

+∞

307.7

337

EB1HA, ,

ICD-O-3

+∞

307.7

451

J01DA01, ,

ATC

[U] cefalexin

+∞

307.7

458

FM1BE, ,

ICD-O-3

+∞

307.7

436

M01AH05, ,

ATC

etoricoxib; oral

+∞

307.7

409

M03BX02, ,

ATC

tizanidine; oral

+∞

307.7

438

WZB00, ,

ICD-O-3

+∞

307.7

354

J01CR02, ,

ATC

amoxicillin and beta-lactamase inhibitor; systemic

+∞

307.7

556

Z012, ,

ICD-O-3

+∞

307.7

486

-1, ,

ICD-O-3

+∞

307.7

372

C03CA01, ,

ATC

furosemide; systemic

+∞

307.7

320

G03CA03, ,

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

+∞

307.7

299

SFA10, ,

ICD-O-3

+∞

307.7

506

N02AJ06, ,

ATC

codeine and paracetamol; systemic

+∞

307.7

330

R01AD09, ,

ATC

mometasone; nasal

+∞

307.7

348

XF400, ,

ICD-O-3

+∞

307.7

349

J01CE02, ,

ATC

phenoxymethylpenicillin; oral

+∞

307.7

579

SPAT1249, ,

ICD-O-3

+∞

307.7

333

WYA05, ,

ICD-O-3

+∞

307.7

396

B01AA03, ,

ATC

warfarin; systemic

+∞

307.7

313

J01AA02, ,

ATC

doxycycline; systemic

+∞

307.7

589

S18, ,

ICD-O-3

+∞

307.7

352

J01CA08, ,

ATC

pivmecillinam; oral

+∞

307.7

303

A02BC02, ,

ATC

pantoprazole; systemic

+∞

307.7

531

EB1AA, ,

ICD-O-3

+∞

307.7

456

SPAT1312, ,

ICD-O-3

+∞

307.7

310

N02AX02, ,

ATC

tramadol; systemic, rectal

+∞

307.7

301

A98, ,

ICD-O-3

+∞

307.7

1050

FM1EE, ,

ICD-O-3

+∞

307.7

556

J069, ,

ICD-O-3

+∞

307.7

499

Q2110, ,

ICD-10 Finland

Persistent ostium secundum

+∞

307.7

832

C07AB07, ,

ATC

bisoprolol; oral

+∞

307.7

464

N02AA59, ,

ATC

codeine, combinations excl. psycholeptics; systemic

+∞

307.7

320

SCA01, ,

ICD-O-3

+∞

307.7

412

ZXE10, ,

ICD-O-3

+∞

307.7

427

H02AB06, ,

ATC

prednisolone; systemic

+∞

307.7

348

R4110, ,

ICD-O-3

+∞

307.7

332

M01AE01, ,

ATC

ibuprofen; systemic, rectal

+∞

307.7

717

WX404, ,

ICD-O-3

+∞

307.7

328

J01CA04, ,

ATC

amoxicillin; systemic

+∞

307.7

930

J01FA06, ,

ATC

roxithromycin; oral

+∞

307.7

296

WZC00, ,

ICD-O-3

+∞

307.7

422

J01DB01, ,

ATC

cefalexin; oral

+∞

307.7

801

SFA30, ,

ICD-O-3

+∞

307.7

303

EB1SA, ,

ICD-O-3

+∞

307.7

486

GD1AA, ,

ICD-O-3

+∞

307.7

644

WX110, ,

ICD-O-3

+∞

307.7

724

EBA00, ,

ICD-O-3

+∞

307.7

337

R74, ,

ICD-O-3

+∞

307.7

307

E0000UV, ,

ATC

+∞

307.7

388

KMAK, ,

ICD-O-3

+∞

307.7

379

N02BE01, ,

ATC

paracetamol; systemic, rectal

+∞

307.7

776

M01AB05, ,

ATC

diclofenac; systemic, rectal

+∞

307.7

433

SPAT1263, ,

ICD-O-3

+∞

307.7

379

ZXE00, ,

ICD-O-3

+∞

307.7

430

K021, ,

ICD-O-3

+∞

307.7

548

Z2221, ,

ICD-O-3

+∞

307.7

347

SFA20, ,

ICD-O-3

+∞

307.7

510

ZXD05, ,

ICD-O-3

+∞

307.7

331

SAA02, ,

ICD-O-3

+∞

307.7

751

SPAT1253, ,

ICD-O-3

+∞

307.7

305

R06AE07, ,

ATC

cetirizine; oral

+∞

307.7

368

M01AE02, ,

ATC

naproxen; oral, rectal

+∞

307.7

515

K0364, ,

ICD-O-3

+∞

305.5

279

P01AB01, ,

ATC

metronidazole; oral, rectal

+∞

302.0

276

M796, ,

ICD-O-3

+∞

302.0

276

WX402, ,

ICD-O-3

+∞

300.9

275

I48, ,

ICD-10 Finland

Atrial fibrillation and flutter

+∞

299.7

274

I10, ,

ICD-10 Finland

Essential (primary) hypertension

+∞

298.6

273

B01AB05, ,

ATC

enoxaparin; parenteral

+∞

298.6

273

SDA01, ,

ICD-O-3

+∞

293.9

269

J02AC01, ,

ATC

fluconazole; systemic

+∞

292.8

268

I10, ,

ICD-O-3

+∞

292.8

268

GD1UA, ,

ICD-O-3

+∞

285.9

262

R05FA02, ,

ATC

opium derivatives and expectorants; systemic

+∞

284.8

261

SPAT1301, ,

ICD-O-3

+∞

280.2

257

R06AX27, ,

ATC

desloratadine; oral

+∞

280.2

257

R104, ,

ICD-10 Finland

Other and unspecified abdominal pain

+∞

276.7

254

SPAT1315, ,

ICD-O-3

+∞

274.4

252

R83, ,

ICD-O-3

+∞

274.4

252

FN1AC, ,

ICD-O-3

+∞

271.0

249

VALMI, ,

ICD-O-3

+∞

269.9

248

R21, ,

ICD-O-3

+∞

268.7

247

R01AD12, ,

ATC

fluticasone furoate; nasal

+∞

266.5

245

N06AX11, ,

ATC

mirtazapine; oral

+∞

266.5

245

J01FA09, ,

ATC

clarithromycin; systemic

+∞

263.0

242

J01MA02, ,

ATC

ciprofloxacin; systemic

+∞

261.9

241

D07AC01, ,

ATC

betamethasone; topical

+∞

259.6

239

WZA90, ,

ICD-O-3

+∞

259.6

239

UJD10, ,

ICD-O-3

+∞

253.9

234

R05FB02, ,

ATC

cough suppressants and expectorants; systemic

+∞

250.5

231

74642, ,

ICD-8 Finland

Congenital anomalies of heart, Defectus septi atriorum, ostium secundum

+∞

250.5

231

J069, ,

ICD-10 Finland

Acute upper respiratory infection, unspecified

+∞

248.3

229

D19, ,

ICD-O-3

+∞

248.3

229

L17, ,

ICD-O-3

+∞

246.0

227

W01, ,

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

+∞

244.9

226

LC2BE, ,

ICD-O-3

+∞

240.4

222

M545, ,

ICD-O-3

+∞

239.2

221

M01AE03, ,

ATC

ketoprofen; systemic, rectal

+∞

238.1

220

Z018, ,

ICD-10 Finland

Other specified special examinations

+∞

238.1

220

C10AA05, ,

ATC

atorvastatin; oral

+∞

237.0

219

SPAT1317, ,

ICD-O-3

+∞

235.8

218

M02AA07, ,

ATC

piroxicam; topical

+∞

234.7

217

C10AA01, ,

ATC

simvastatin; oral

+∞

234.7

217

OAB43, ,

ICD-O-3

+∞

233.6

216

J01FF01, ,

ATC

clindamycin; systemic

+∞

233.6

216

TPH04, ,

ICD-O-3

+∞

232.5

215

FXA00, ,

ICD-O-3

+∞

231.3

214

N05CF01, ,

ATC

zopiclone; oral

+∞

225.7

209

A12AX, ,

ATC

Calcium, combinations with vitamin D and/or other drugs

+∞

224.6

208

S01CA01, ,

ATC

dexamethasone and antiinfectives; ophthalmic

+∞

223.5

207

FM1DE, ,

ICD-O-3

+∞

223.5

207

AA1AD, ,

ICD-O-3

+∞

223.5

207

Z3226, ,

ICD-O-3

+∞

220.1

204

D07AB02, ,

ATC

hydrocortisone butyrate; topical

+∞

219.0

203

J01EA01, ,

ATC

trimethoprim; systemic

+∞

217.9

202

SPAT1153, ,

ICD-O-3

+∞

217.9

202

M01AC06, ,

ATC

meloxicam; systemic, rectal

+∞

216.7

201

SFC01, ,

ICD-O-3

+∞

215.6

200

R01AD08, ,

ATC

fluticasone; nasal

+∞

215.6

200

TPH07, ,

ICD-O-3

+∞

215.6

200

SPAT1223, ,

ICD-O-3

+∞

215.6

200

K020, ,

ICD-O-3

+∞

214.5

199

A03, ,

ICD-O-3

+∞

213.4

198

SCA02, ,

ICD-O-3

+∞

212.3

197

R060, ,

ICD-10 Finland

Dyspnoea

+∞

210.0

195

SDA04, ,

ICD-O-3

+∞

210.0

195

XF404, ,

ICD-O-3

+∞

210.0

195

SPAT1283, ,

ICD-O-3

+∞

208.9

194

L03, ,

ICD-O-3

+∞

207.8

193

207, ,

Kela drug reimbursment

Chronic arrhythmias

+∞

207.8

193

C08CA01, ,

ATC

amlodipine; oral

+∞

207.8

193

Z001, ,

ICD-O-3

+∞

205.6

191

A02BC01, ,

ATC

omeprazole; systemic

+∞

204.5

190

Q2119, ,

ICD-10 Finland

Atrial septal defect NOS

+∞

202.2

188

Z712, ,

ICD-O-3

+∞

201.1

187

WX700, ,

ICD-O-3

+∞

200.0

186

Z718, ,

ICD-10 Finland

Other specified counselling

+∞

198.9

185

Z760, ,

ICD-O-3

+∞

198.9

185

R074, ,

ICD-10 Finland

Chest pain, unspecified

+∞

197.8

184

ZXE20, ,

ICD-O-3

+∞

195.6

182

FFC22, ,

ICD-O-3

+∞

195.6

182

UJF32, ,

ICD-O-3

+∞

194.4

181

N05BA04, ,

ATC

oxazepam; oral

+∞

193.3

180

SDE02, ,

ICD-O-3

+∞

193.3

180

WW200, ,

ICD-O-3

+∞

192.2

179

C07AA05, ,

ATC

propranolol; systemic

+∞

190.0

177

M255, ,

ICD-O-3

+∞

188.9

176

J189, ,

ICD-10 Finland

Pneumonia, unspecified

+∞

188.9

176

R05DA20, ,

ATC

opium alkaloids and derivatives - combinations

+∞

187.8

175

JN3AE, ,

ICD-O-3

+∞

186.7

174

A02BC03, ,

ATC

lansoprazole; oral

+∞

186.7

174

I48, ,

ICD-O-3

+∞

186.7

174

D07AC13, ,

ATC

mometasone; topical

+∞

185.6

173

C10AA07, ,

ATC

rosuvastatin; oral

+∞

185.6

173

TPH15, ,

ICD-O-3

+∞

183.4

171

SAB03, ,

ICD-O-3

+∞

181.1

169

C09AA05, ,

ATC

ramipril; oral

+∞

181.1

169

R03BA05, ,

ATC

fluticasone; inhalant

+∞

181.1

169

ZXA00, ,

ICD-O-3

+∞

180.0

168

ZXA10, ,

ICD-O-3

+∞

180.0

168

SAB01, ,

ICD-O-3

+∞

180.0

168

203, ,

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

+∞

178.9

167

SDE03, ,

ICD-O-3

+∞

177.8

166

J01DA09, ,

ATC

[U] cefadroxil

+∞

176.7

165

290, ,

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

+∞

176.7

165

L15, ,

ICD-O-3

+∞

176.7

165

Z010, ,

ICD-10 Finland

Examination of eyes and vision

+∞

175.6

164

M03BC51, ,

ATC

orphenadrine, combinations; systemic

+∞

175.6

164

Z718, ,

ICD-O-3

+∞

174.5

163

R01AD58, ,

ATC

fluticasone, combinations; nasal

+∞

173.4

162

R01BA52, ,

ATC

pseudoephedrine, combinations; oral

+∞

173.4

162

A06AC01, ,

ATC

ispaghula (psylla seeds); oral

+∞

172.3

161

K0382, ,

ICD-O-3

+∞

171.2

160

C09CA06, ,

ATC

candesartan; oral

+∞

169.0

158

201, ,

Kela drug reimbursment

Chronic cardiac insufficiency

+∞

169.0

158

D01AC20, ,

ATC

imidazoles/triazoles in combination with corticosteroids; topical

+∞

167.9

157

WZC30, ,

ICD-O-3

+∞

167.9

157

C07AB02, ,

ATC

metoprolol; systemic

+∞

167.9

157

C03DA01, ,

ATC

spironolactone; oral

+∞

166.8

156

K045, ,

ICD-O-3

+∞

166.8

156

EBA05, ,

ICD-O-3

+∞

166.8

156

WX002, ,

ICD-O-3

+∞

165.7

155

Z039, ,

ICD-10 Finland

Observation for suspected disease or condition, unspecified

+∞

165.7

155

H03AA01, ,

ATC

levothyroxine sodium; systemic

+∞

164.6

154

R509, ,

ICD-10 Finland

Fever, unspecified

+∞

164.6

154

SPAT1260, ,

ICD-O-3

+∞

163.5

153

N06AB10, ,

ATC

escitalopram; oral

+∞

162.4

152

SPAT1316, ,

ICD-O-3

+∞

162.4

152

SAD01, ,

ICD-O-3

+∞

162.4

152

M03BC01, ,

ATC

orphenadrine (citrate); systemic

+∞

160.2

150

R03AK07, ,

ATC

formoterol and budesonide; inhalant

+∞

160.2

150

ZXA05, ,

ICD-O-3

+∞

159.1

149

L08, ,

ICD-O-3

+∞

158.0

148

XF402, ,

ICD-O-3

+∞

158.0

148

X59, ,

ICD-10 Finland

Exposure to unspecified factor

+∞

158.0

148

E000001, ,

ATC

+∞

156.9

147

S01GX01, ,

ATC

cromoglicic acid; ophthalmic

+∞

155.8

146

R03BA02, ,

ATC

budesonide; inhalant

+∞

155.8

146

J010, ,

ICD-O-3

+∞

154.7

145

FFC00, ,

ICD-O-3

+∞

154.7

145

J05AB01, ,

ATC

aciclovir; systemic

+∞

152.5

143

XF600, ,

ICD-O-3

+∞

152.5

143

CJE20, ,

ICD-O-3

+∞

152.5

143

J459, ,

ICD-10 Finland

Asthma, unspecified

+∞

151.4

142

351, ,

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

+∞

151.4

142

C01AA05, ,

ATC

digoxin; systemic

+∞

150.3

141

R53, ,

ICD-O-3

+∞

150.3

141

M796, ,

ICD-10 Finland

Pain in limb

+∞

150.3

141

TFP20, ,

ICD-O-3

+∞

150.3

141

N03AX16, ,

ATC

[U] pregabalin

+∞

149.2

140

K0365, ,

ICD-O-3

+∞

148.2

139

O800, ,

ICD-10 Finland

Spontaneous vertex delivery

+∞

147.1

138

R104, ,

ICD-O-3

+∞

146.0

137

L12, ,

ICD-O-3

+∞

144.9

136

I509, ,

ICD-10 Finland

Heart failure, unspecified

+∞

143.8

135

Z035, ,

ICD-10 Finland

Observation for other suspected cardiovascular diseases

+∞

142.7

134

Q2111, ,

ICD-10 Finland

Paten or persistent foramen ovale

+∞

142.7

134

A09, ,

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

+∞

141.6

133

SPAT1254, ,

ICD-O-3

+∞

141.6

133

C01DA08, ,

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

+∞

141.6

133

S29, ,

ICD-O-3

+∞

140.5

132

N01, ,

ICD-O-3

+∞

138.3

130

XF620, ,

ICD-O-3

+∞

138.3

130

G473, ,

ICD-10 Finland

Sleep apnoea

+∞

138.3

130

N05AH04, ,

ATC

quetiapine; oral

+∞

137.2

129

U072, ,

ICD-O-3

+∞

137.2

129

R060, ,

ICD-O-3

+∞

136.2

128

A97, ,

ICD-O-3

+∞

136.2

128

SPAT1250, ,

ICD-O-3

+∞

136.2

128

N06AB04, ,

ATC

citalopram; systemic

+∞

135.1

127

SFA40, ,

ICD-O-3

+∞

135.1

127

C09CA01, ,

ATC

losartan; oral

+∞

135.1

127

D07AA02, ,

ATC

hydrocortisone; topical

+∞

134.0

126

65000, ,

ICD-8 Finland

Delivery without mention of complication, Occipital presentation

+∞

134.0

126

A03FA01, ,

ATC

metoclopramide; systemic, rectal

+∞

134.0

126

A10BA02, ,

ATC

metformin; oral

+∞

132.9

125

R03DC03, ,

ATC

montelukast; oral

+∞

131.8

124

U071, ,

ICD-O-3

+∞

131.8

124

L01, ,

ICD-O-3

+∞

131.8

124

103, ,

Kela drug reimbursment

Diabetes, insulin-treated

+∞

131.8

124

205, ,

Kela drug reimbursment

Chronic hypertension

+∞

130.7

123

B01AF02, ,

ATC

apixaban; oral

+∞

130.7

123

Z0389, ,

ICD-10 Finland

Observation for other suspected diseases and conditions

+∞

130.7

123

J01MA12, ,

ATC

levofloxacin; systemic

+∞

130.7

123

Z011, ,

ICD-10 Finland

Examination of ears and hearing

+∞

129.6

122

EBA10, ,

ICD-O-3

+∞

129.6

122

GD1QA, ,

ICD-O-3

+∞

128.5

121

FM2CE, ,

ICD-O-3

+∞

127.5

120

N02CC01, ,

ATC

sumatriptan; nasal, systemic, rectal

+∞

127.5

120

H01, ,

ICD-O-3

+∞

127.5

120

7455A, ,

ICD-9 Finland

Bulbus cordis anomalies and anomalies of cardiac septal closure, Ostium secundum type atrial septal defect

+∞

126.4

119

I251, ,

ICD-10 Finland

Atherosclerotic heart disease

+∞

126.4

119

WX320, ,

ICD-O-3

+∞

125.3

118

Z363, ,

ICD-10 Finland

Antenatal screening for malformations using ultrasound and other physical methods

+∞

124.2

117

SBB10, ,

ICD-O-3

+∞

124.2

117

D01BA02, ,

ATC

terbinafine; oral

+∞

124.2

117

F510, ,

ICD-O-3

+∞

124.2

117

R42, ,

ICD-10 Finland

Dizziness and giddiness

+∞

124.2

117

C09AA02, ,

ATC

enalapril; systemic

+∞

123.1

116

SAB02, ,

ICD-O-3

+∞

123.1

116

WX892, ,

ICD-O-3

+∞

123.1

116

M01AX17, ,

ATC

nimesulide; oral

+∞

122.0

115

A04, ,

ICD-O-3

+∞

121.0

114

SXC05, ,

ICD-O-3

+∞

121.0

114

WX105, ,

ICD-O-3

+∞

121.0

114

B01AC04, ,

ATC

clopidogrel; oral

+∞

119.9

113

OAA65, ,

ICD-O-3

+∞

119.9

113

H660, ,

ICD-10 Finland

Acute suppurative otitis media

+∞

119.9

113

R103, ,

ICD-10 Finland

Pain localized to other parts of lower abdomen

+∞

118.8

112

R103, ,

ICD-O-3

+∞

118.8

112

215, ,

Kela drug reimbursment

Diabetes, non-insulin-treated

+∞

118.8

112

SPAT1097, ,

ICD-O-3

+∞

117.7

111

R06AX22, ,

ATC

ebastine; oral

+∞

116.6

110

J209, ,

ICD-O-3

+∞

116.6

110

P01, ,

ICD-O-3

+∞

116.6

110

SPAT1324, ,

ICD-O-3

+∞

115.5

109

GD1PA, ,

ICD-O-3

+∞

115.5

109

SPAT1308, ,

ICD-O-3

+∞

115.5

109

X58, ,

ICD-10 Finland

Exposure to other specified factors

+∞

114.5

108

I639, ,

ICD-10 Finland

Cerebral infarction, unspecified

+∞

114.5

108

OAA40, ,

ICD-O-3

+∞

114.5

108

L28, ,

ICD-O-3

+∞

114.5

108

Z2446, ,

ICD-O-3

+∞

114.5

108

ZYC01, ,

ICD-O-3

+∞

113.4

107

J01DA08, ,

ATC

[U] cefaclor

+∞

113.4

107

J01AA07, ,

ATC

tetracycline; systemic

+∞

113.4

107

OAA67, ,

ICD-O-3

+∞

112.3

106

T90, ,

ICD-O-3

+∞

112.3

106

L309, ,

ICD-O-3

+∞

111.2

105

M751, ,

ICD-O-3

+∞

111.2

105

Z024, ,

ICD-O-3

+∞

111.2

105

H13, ,

ICD-O-3

+∞

110.1

104

N05CF02, ,

ATC

zolpidem; oral

+∞

110.1

104

R5110, ,

ICD-O-3

+∞

109.1

103

M01AG02, ,

ATC

tolfenamic acid; oral, rectal

+∞

109.1

103

R03AK06, ,

ATC

salmeterol and fluticasone; inhalant

+∞

109.1

103

K78, ,

ICD-O-3

+∞

108.0

102

B02AA02, ,

ATC

tranexamic acid; systemic

+∞

108.0

102

SPAT1222, ,

ICD-O-3

+∞

108.0

102

L16, ,

ICD-O-3

+∞

108.0

102

H02AB04, ,

ATC

methylprednisolone; systemic

+∞

108.0

102

G01AA10, ,

ATC

clindamycin; vaginal

+∞

108.0

102

H660, ,

ICD-O-3

+∞

108.0

102

M255, ,

ICD-10 Finland

Pain in joint

+∞

108.0

102

A09, ,

ICD-O-3

+∞

108.0

102

K0510, ,

ICD-O-3

+∞

106.9

101

M545, ,

ICD-10 Finland

Low back pain

+∞

105.8

100

M02AA10, ,

ATC

ketoprofen; topical

+∞

105.8

100

R5180, ,

ICD-10 Finland

Headache

+∞

105.8

100

Q2100, ,

ICD-10 Finland

Multiple ventricular septal defect

+∞

105.8

100

R01BA51, ,

ATC

phenylpropanolamine, combinations; oral

+∞

104.8

WX882, ,

ICD-O-3

+∞

103.7

XFP20, ,

ICD-O-3

+∞

103.7

PH2AE, ,

ICD-O-3

+∞

103.7

Z004, ,

ICD-10 Finland

General psychiatric examination, not elsewhere classified

+∞

103.7

SPAT1262, ,

ICD-O-3

+∞

103.7

R02, ,

ICD-O-3

+∞

102.6

J01DA06, ,

ATC

[U] cefuroxime

+∞

102.6

SPAT1156, ,

ICD-O-3

+∞

102.6

D01, ,

ICD-O-3

+∞

102.6

SGA01, ,

ICD-O-3

+∞

101.5

R06AE09, ,

ATC

levocetirizine; oral

+∞

101.5

NG1AA, ,

ICD-O-3

+∞

101.5

ZXD20, ,

ICD-O-3

+∞

101.5

H669, ,

ICD-O-3

+∞

101.5

A28, ,

ICD-O-3

+∞

101.5

SPAT1306, ,

ICD-O-3

+∞

100.4

SFA00, ,

ICD-O-3

+∞

100.4

WYA30, ,

ICD-O-3

+∞

100.4

B01AF01, ,

ATC

rivaroxaban; oral

+∞

100.4

R074, ,

ICD-O-3

+∞

99.4

TFC00, ,

ICD-O-3

+∞

99.4

D07CA01, ,

ATC

hydrocortisone and antibiotics; topical

+∞

99.4

ZXE30, ,

ICD-O-3

+∞

99.4

J459, ,

ICD-O-3

+∞

99.4

H251, ,

ICD-10 Finland

Senile nuclear cataract

+∞

98.3

L02, ,

ICD-O-3

+∞

98.3

WX872, ,

ICD-O-3

+∞

98.3

R42, ,

ICD-O-3

+∞

98.3

J02AC02, ,

ATC

itraconazole; systemic

+∞

97.2

M544, ,

ICD-O-3

+∞

97.2

SPAT1033, ,

ICD-O-3

+∞

97.2

OAB48, ,

ICD-O-3

+∞

97.2

P03, ,

ICD-O-3

+∞

97.2

J05AB11, ,

ATC

valaciclovir; oral

+∞

97.2

Z017, ,

ICD-O-3

+∞

97.2

R2130, ,

ICD-O-3

+∞

97.2

L13, ,

ICD-O-3

+∞

97.2

EB1VA, ,

ICD-O-3

+∞

96.1

SPAT1230, ,

ICD-O-3

+∞

96.1

Q2109, ,

ICD-10 Finland

Ventricular septal defect NOS

+∞

96.1

Q2108, ,

ICD-10 Finland

Other specifed ventricular septal defect

+∞

96.1

LC2AE, ,

ICD-O-3

+∞

96.1

SPAT1363, ,

ICD-O-3

+∞

96.1

J01FA01, ,

ATC

erythromycin; systemic

+∞

95.1

SPAT1384, ,

ICD-O-3

+∞

95.1

Z315, ,

ICD-10 Finland

Genetic counselling

+∞

95.1

SPAT1216, ,

ICD-O-3

+∞

95.1

R03BA01, ,

ATC

beclometasone; inhalant

+∞

95.1

NH3AA, ,

ICD-O-3

+∞

95.1

E780, ,

ICD-O-3

+∞

95.1

A02BA02, ,

ATC

ranitidine; systemic

+∞

94.0

N17, ,

ICD-O-3

+∞

94.0

R238, ,

ICD-O-3

+∞

94.0

Z000, ,

ICD-10 Finland

General medical examination

+∞

94.0

R05, ,

ICD-10 Finland

Cough

+∞

92.9

W19, ,

ICD-10 Finland

Unspecified fall

+∞

92.9

JN3AD, ,

ICD-O-3

+∞

92.9

M791, ,

ICD-O-3

+∞

92.9

AA1BG, ,

ICD-O-3

+∞

92.9

I499, ,

ICD-10 Finland

Cardiac arrhythmia, unspecified

+∞

92.9

Z3229, ,

ICD-O-3

+∞

91.9

H81, ,

ICD-O-3

+∞

91.9

MA2AE, ,

ICD-O-3

+∞

91.9

31, ,

ICD-O-3

+∞

91.9

N06AX16, ,

ATC

venlafaxine; oral

+∞

91.9

C01DA02, ,

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

+∞

91.9

EB4VA, ,

ICD-O-3

+∞

91.9

J01AA04, ,

ATC

lymecycline; systemic

+∞

91.9

H02AB07, ,

ATC

prednisone; oral

+∞

90.8

N03AX12, ,

ATC

[U] gabapentin; oral

+∞

89.7

R01AD01, ,

ATC

beclometasone; nasal

+∞

89.7

SGA02, ,

ICD-O-3

+∞

89.7

Z048, ,

ICD-10 Finland

Examination and observation for other specified reasons

+∞

89.7

Q2110, ,

ICD-O-3

+∞

89.7

WX704, ,

ICD-O-3

+∞

89.7

UKC02, ,

ICD-O-3

+∞

89.7

6500B, ,

ICD-9 Finland

Delivery in a completely normal case[PARTUS SINE COMPLICATIONE]

+∞

89.7

AN1, ,

ICD-O-3

+∞

89.7

ZX120, ,

ICD-O-3

+∞

89.7

K80, ,

ICD-O-3

+∞

89.7

R03CC02, ,

ATC

salbutamol; systemic

+∞

88.6

K573, ,

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

+∞

88.6

W11, ,

ICD-O-3

+∞

88.6

I351, ,

ICD-10 Finland

Aortic (valve) insufficiency

+∞

88.6

M171, ,

ICD-10 Finland

Other primary gonarthrosis

+∞

87.6

R03AC03, ,

ATC

terbutaline; inhalant

+∞

87.6

C03EA01, ,

ATC

hydrochlorothiazide and potassium-sparing agents; oral

+∞

87.6

K0366, ,

ICD-O-3

+∞

87.6

A29, ,

ICD-O-3

+∞

87.6

SPAT1383, ,

ICD-O-3

+∞

86.5

E000002, ,

ATC

+∞

86.5

R06AX13, ,

ATC

loratadine; oral

+∞

86.5

N06AB06, ,

ATC

sertraline; oral

+∞

86.5

Z015, ,

ICD-10 Finland

Diagnostic skin and sensitization tests

+∞

86.5

OAB44, ,

ICD-O-3

+∞

86.5

J451, ,

ICD-10 Finland

Nonallergic asthma

+∞

86.5

D07AD01, ,

ATC

clobetasol; topical

+∞

86.5

I480, ,

ICD-10 Finland

Paroxysmal atrial fibrillation

+∞

85.4

LCA06, ,

ICD-O-3

+∞

85.4

SPAT1149, ,

ICD-O-3

+∞

85.4

UDC00, ,

ICD-O-3

+∞

85.4

N05BA01, ,

ATC

diazepam; systemic, rectal

+∞

85.4

I500, ,

ICD-10 Finland

Congestive heart failure

+∞

85.4

U02, ,

ICD-O-3

+∞

84.4

SPAT1211, ,

ICD-O-3

+∞

83.3

E119, ,

ICD-10 Finland

Type 2 diabetes mellitus, without complications

+∞

83.3

L82, ,

ICD-O-3

+∞

83.3

D11, ,

ICD-O-3

+∞

83.3

Z950, ,

ICD-10 Finland

Presence of electronic cardiac devices

+∞

83.3

M01AH01, ,

ATC

celecoxib; oral

+∞

83.3

W78, ,

ICD-O-3

+∞

83.3

JN1AE, ,

ICD-O-3

+∞

82.2

I693, ,

ICD-10 Finland

Sequelae of cerebral infarction

+∞

82.2

K0530, ,

ICD-O-3

+∞

82.2

NA3AA, ,

ICD-O-3

+∞

82.2

ZXE11, ,

ICD-O-3

+∞

82.2

SPAT1240, ,

ICD-O-3

+∞

82.2

Z000, ,

ICD-O-3

+∞

81.2

SHB00, ,

ICD-O-3

+∞

81.2

AA1CG, ,

ICD-O-3

+∞

81.2

N300, ,

ICD-O-3

+∞

81.2

XLD00, ,

ICD-O-3

+∞

81.2

D07BB04, ,

ATC

hydrocortisone butyrate and antiseptics; topical

+∞

80.1

F329, ,

ICD-10 Finland

Depressive episode, unspecified

+∞

80.1

C10AX09, ,

ATC

ezetimibe; oral

+∞

80.1

Z712, ,

ICD-10 Finland

Person consulting for explanation of investigation findings

+∞

80.1

ND2AA, ,

ICD-O-3

+∞

80.1

J189, ,

ICD-O-3

+∞

80.1

Z258, ,

ICD-O-3

+∞

79.0

A06AD11, ,

ATC

lactulose; oral

+∞

79.0

DFF00, ,

ICD-O-3

+∞

79.0

I3409, ,

ICD-10 Finland

Mitral (valve) insufficiency

+∞

79.0

R101, ,

ICD-O-3

+∞

79.0

R53, ,

ICD-10 Finland

Malaise and fatigue

+∞

79.0

G03DB01, ,

ATC

dydrogesterone; oral

+∞

79.0

H29, ,

ICD-O-3

+∞

79.0

XA800, ,

ICD-O-3

+∞

77.9

N06AB03, ,

ATC

fluoxetine; oral

+∞

77.9

F03, ,

ICD-O-3

+∞

76.9

DCA20, ,

ICD-O-3

+∞

76.9

HMAK, ,

ICD-O-3

+∞

76.9

SGB10, ,

ICD-O-3

+∞

76.9

M01AX05, ,

ATC

glucosamine; oral

+∞

76.9

F29, ,

ICD-O-3

+∞

76.9

M706, ,

ICD-O-3

+∞

75.8

Z016, ,

ICD-O-3

+∞

75.8

W00, ,

ICD-10 Finland

Fall on same level involving ice and snow

+∞

75.8

J450, ,

ICD-10 Finland

Predominantly allergic asthma

+∞

75.8

FN1BC, ,

ICD-O-3

+∞

75.8

G473, ,

ICD-O-3

+∞

75.8

SGB30, ,

ICD-O-3

+∞

75.8

NF1AA, ,

ICD-O-3

+∞

75.8

M04AA01, ,

ATC

allopurinol; systemic

+∞

75.8

LX1AE, ,

ICD-O-3

+∞

75.8

Z508, ,

ICD-10 Finland

Care involving use of other rehabilitation procedures

+∞

74.7

206, ,

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

+∞

74.7

TLC00, ,

ICD-O-3

+∞

74.7

A499, ,

ICD-10 Finland

Bacterial infection, unspecified

+∞

74.7

5205, ,

ICD-O-3

+∞

74.7

N02AA05, ,

ATC

oxycodone; systemic

+∞

74.7

M54, ,

ICD-O-3

+∞

74.7

H903, ,

ICD-10 Finland

Sensorineural hearing loss, bilateral

+∞

73.7

S82, ,

ICD-O-3

+∞

73.7

S21, ,

ICD-O-3

+∞

73.7

I471, ,

ICD-10 Finland

Supraventricular tachycardia

+∞

73.7

OAB42, ,

ICD-O-3

+∞

73.7

MA2HE, ,

ICD-O-3

+∞

73.7

C08CA13, ,

ATC

lercanidipine; oral

+∞

73.7

EB1CA, ,

ICD-O-3

+∞

72.6

P06, ,

ICD-O-3

+∞

72.6

SPAT1148, ,

ICD-O-3

+∞

72.6

N02AE01, ,

ATC

buprenorphine; parenteral, sublingual, transdermal

+∞

72.6

SPAT1385, ,

ICD-O-3

+∞

72.6

JKA21, ,

ICD-O-3

+∞

72.6

G04CA02, ,

ATC

tamsulosin; oral

+∞

71.6

TQW40, ,

ICD-O-3

+∞

71.6

R4120, ,

ICD-O-3

+∞

71.6

D07BA04, ,

ATC

hydrocortisone and antiseptics; topical

+∞

71.6

K802, ,

ICD-10 Finland

Calculus of gallbladder without cholecystitis

+∞

71.6

K021, ,

ICD-10 Finland

Caries of dentine

+∞

71.6

L11, ,

ICD-O-3

+∞

71.6

Z358, ,

ICD-10 Finland

Supervision of other high-risk pregnancies

+∞

71.6

R509, ,

ICD-O-3

+∞

71.6

SPAT1192, ,

ICD-O-3

+∞

71.6

Z2445, ,

ICD-O-3

+∞

71.6

J45, ,

ICD-O-3

+∞

71.6

N390, ,

ICD-10 Finland

Urinary tract infection, site not specified

+∞

71.6

N10, ,

ICD-10 Finland

Acute tubulo-interstitial nephritis

+∞

71.6

WZA00, ,

ICD-O-3

+∞

70.5

ZXE04, ,

ICD-O-3

+∞

70.5

I493, ,

ICD-10 Finland

Ventricular premature depolarization

+∞

70.5

J20, ,

ICD-O-3

+∞

70.5

SGA04, ,

ICD-O-3

+∞

70.5

L200, ,

ICD-10 Finland

Besnier prurigo

+∞

69.4

I499, ,

ICD-O-3

+∞

69.4

R55, ,

ICD-10 Finland

Syncope and collapse

+∞

69.4

Z014, ,

ICD-10 Finland

Gynaecological examination (general)(routine)

+∞

69.4

S934, ,

ICD-O-3

+∞

69.4

L309, ,

ICD-10 Finland

Dermatitis, unspecified

+∞

69.4

D07AB08, ,

ATC

desonide; topical

+∞

69.4

FM1DG, ,

ICD-O-3

+∞

69.4

D07CC01, ,

ATC

betamethasone and antibiotics; topical

+∞

69.4

E11, ,

ICD-O-3

+∞

69.4

A46, ,

ICD-10 Finland

Erysipelas

+∞

69.4

XCW99, ,

ICD-O-3

+∞

69.4

E7801, ,

ICD-10 Finland

Pure hypercholesterolaemia

+∞

69.4

UJF30, ,

ICD-O-3

+∞

68.4

R4190, ,

ICD-O-3

+∞

68.4

NA3BG, ,

ICD-O-3

+∞

68.4

XG412, ,

ICD-O-3

+∞

68.4

A99, ,

ICD-O-3

+∞

68.4

J159, ,

ICD-10 Finland

Bacterial pneumonia, unspecified

+∞

68.4

SHA01, ,

ICD-O-3

+∞

68.4

C05AA08, ,

ATC

fluocortolone; rectal, topical

+∞

68.4

Z450, ,

ICD-10 Finland

Adjustment and management of cardiac devices

+∞

68.4

R040, ,

ICD-10 Finland

Epistaxis

+∞

67.3

SPAT1292, ,

ICD-O-3

+∞

67.3

N832, ,

ICD-10 Finland

Other and unspecified ovarian cysts

+∞

67.3

SGC10, ,

ICD-O-3

+∞

67.3

E119, ,

ICD-O-3

+∞

67.3

Z03, ,

ICD-O-3

+∞

67.3

J209, ,

ICD-10 Finland

Acute bronchitis, unspecified

+∞

67.3

N951, ,

ICD-O-3

+∞

67.3

R5140, ,

ICD-O-3

+∞

67.3

I489, ,

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

+∞

67.3

D10, ,

ICD-O-3

+∞

67.3

XX3DW, ,

ICD-O-3

+∞

67.3

H653, ,

ICD-10 Finland

Chronic mucoid otitis media

+∞

66.2

C01DA14, ,

ATC

isosorbide mononitrate; oral

+∞

66.2

TQX10, ,

ICD-O-3

+∞

66.2

NB1AA, ,

ICD-O-3

+∞

66.2

SPAT1220, ,

ICD-O-3

+∞

66.2

I495, ,

ICD-10 Finland

Sick sinus syndrome

+∞

66.2

W12, ,

ICD-O-3

+∞

66.2

MA2DE, ,

ICD-O-3

+∞

66.2

NH1AA, ,

ICD-O-3

+∞

66.2

D07BC01, ,

ATC

betamethasone and antiseptics; topical

+∞

66.2

J01MA06, ,

ATC

norfloxacin; oral

+∞

65.2

JN4AD, ,

ICD-O-3

+∞

65.2

XQ800, ,

ICD-O-3

+∞

65.2

SGC00, ,

ICD-O-3

+∞

65.2

J010, ,

ICD-10 Finland

Acute maxillary sinusitis

+∞

65.2

H669, ,

ICD-10 Finland

Otitis media, unspecified

+∞

65.2

S060, ,

ICD-10 Finland

Concussion

+∞

64.1

G03HB01, ,

ATC

cyproterone and estrogen; oral

+∞

64.1

R101, ,

ICD-10 Finland

Pain localized to upper abdomen

+∞

64.1

ZXE06, ,

ICD-O-3

+∞

64.1

R96, ,

ICD-O-3

+∞

64.1

K0730, ,

ICD-O-3

+∞

64.1

D06BX01, ,

ATC

metronidazole; topical

+∞

64.1

Z014, ,

ICD-O-3

+∞

64.1

SBB00, ,

ICD-O-3

+∞

63.0

Z100, ,

ICD-O-3

+∞

63.0

SPAT1016, ,

ICD-O-3

+∞

63.0

WX602, ,

ICD-O-3

+∞

63.0

H10, ,

ICD-O-3

+∞

63.0

G02BA03, ,

ATC

plastic IUD with progestogen

+∞

63.0

N300, ,

ICD-10 Finland

Acute cystitis

+∞

63.0

L29, ,

ICD-O-3

+∞

63.0

K02, ,

ICD-O-3

+∞

63.0

G03AC03, ,

ATC

levonorgestrel; oral, implant

+∞

63.0

G03FA01, ,

ATC

norethisterone and estrogen; systemic

+∞

63.0

A23, ,

ICD-O-3

+∞

62.0

N06AX21, ,

ATC

duloxetine; oral

+∞

62.0

G431, ,

ICD-10 Finland

Migraine with aura [classical migraine]

+∞

62.0

Z348, ,

ICD-10 Finland

Supervision of other normal pregnancy

+∞

62.0

WZC05, ,

ICD-O-3

+∞

62.0

D07XC01, ,

ATC

betamethasone; topical

+∞

62.0

SPAT1307, ,

ICD-O-3

+∞

60.9

FB1BD, ,

ICD-O-3

+∞

60.9

A084, ,

ICD-10 Finland

Viral intestinal infection, unspecified

+∞

60.9

SPAT1212, ,

ICD-O-3

+∞

60.9

K0880, ,

ICD-O-3

+∞

60.9

N390, ,

ICD-O-3

+∞

60.9

SJD40, ,

ICD-O-3

+∞

60.9

JN3BD, ,

ICD-O-3

+∞

60.9

N05CD07, ,

ATC

temazepam; oral

+∞

60.9

F419, ,

ICD-O-3

+∞

59.9

50099, ,

ICD-8 Finland

Hypertrophy of tonsils and adenoids

+∞

59.9

K85, ,

ICD-O-3

+∞

59.9

ZXE03, ,

ICD-O-3

+∞

59.9

SCA03, ,

ICD-O-3

+∞

59.9

K219, ,

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

+∞

59.9

SPAT1386, ,

ICD-O-3

+∞

59.9

SPAT1043, ,

ICD-O-3

+∞

59.9

A03FA02, ,

ATC

cisapride; oral, rectal

+∞

59.9

E039, ,

ICD-O-3

+∞

59.9

202, ,

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

+∞

59.9

EMB30, ,

ICD-O-3

+∞

59.9

D01AE16, ,

ATC

amorolfine; topical

+∞

59.9

T814, ,

ICD-10 Finland

Infection following a procedure, not elsewhere classified

+∞

59.9

R03BA08, ,

ATC

ciclesonide; inhalant

+∞

59.9

N05AX08, ,

ATC

risperidone; systemic

+∞

59.9

ND1AA, ,

ICD-O-3

+∞

59.9

H02, ,

ICD-O-3

+∞

59.9

MCA10, ,

ICD-O-3

+∞

59.9

ZY020, ,

ICD-O-3

+∞

59.9

SCE00, ,

ICD-O-3

+∞

59.9

D06, ,

ICD-O-3

+∞

58.8

WX100, ,

ICD-O-3

+∞

58.8

A46, ,

ICD-O-3

+∞

58.8

M531, ,

ICD-O-3

+∞

58.8

C07AA07, ,

ATC

sotalol; systemic

+∞

58.8

J01FA15, ,

ATC

telithromycin; oral

+∞

58.8

R298, ,

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

+∞

58.8

EB1MA, ,

ICD-O-3

+∞

58.8

WYA50, ,

ICD-O-3

+∞

58.8

G442, ,

ICD-O-3

+∞

58.8

K409, ,

ICD-10 Finland

Unilateral or unspecified inguinal hernia, without obstruction or gangrene

+∞

58.8

SPAT1281, ,

ICD-O-3

+∞

58.8

NK6QA, ,

ICD-O-3

+∞

58.8

K040, ,

ICD-O-3

+∞

58.8

SPAT1193, ,

ICD-O-3

+∞

58.8

D10AX03, ,

ATC

azelaic acid; topical

+∞

58.8

D06AX01, ,

ATC

fusidic acid; topical

+∞

57.7

D649, ,

ICD-10 Finland

Anaemia, unspecified

+∞

57.7

M751, ,

ICD-10 Finland

Rotator cuff syndrome

+∞

57.7

SAA04, ,

ICD-O-3

+∞

57.7

K041, ,

ICD-O-3

+∞

57.7

ULA02, ,

ICD-O-3

+∞

57.7

G03FB05, ,

ATC

norethisterone and estrogen; systemic

+∞

56.7

SJF01, ,

ICD-O-3

+∞

56.7

Z301, ,

ICD-O-3

+∞

56.7

I509, ,

ICD-O-3

+∞

56.7

M01AC01, ,

ATC

piroxicam; systemic, rectal

+∞

56.7

OAA80, ,

ICD-O-3

+∞

56.7

F412, ,

ICD-O-3

+∞

56.7

SPAT1382, ,

ICD-O-3

+∞

56.7

I361, ,

ICD-10 Finland

Nonrheumatic tricuspid (valve) insufficiency

+∞

56.7

H100, ,

ICD-O-3

+∞

56.7

UDH02, ,

ICD-O-3

+∞

56.7

M01AH02, ,

ATC

rofecoxib; oral

+∞

55.6

KC1EE, ,

ICD-O-3

+∞

55.6

N06AX26, ,

ATC

vortioxetine; oral

+∞

55.6

XKD00, ,

ICD-O-3

+∞

55.6

A11, ,

ICD-O-3

+∞

55.6

ZXD30, ,

ICD-O-3

+∞

55.6

Z0389, ,

ICD-O-3

+∞

55.6

111, ,

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

+∞

55.6

H258, ,

ICD-10 Finland

Other senile cataract

+∞

55.6

UGC12, ,

ICD-O-3

+∞

55.6

SDE04, ,

ICD-O-3

+∞

55.6

ZXE05, ,

ICD-O-3

+∞

55.6

P20, ,

ICD-O-3

+∞

55.6

SPAT1305, ,

ICD-O-3

+∞

55.6

KH1AE, ,

ICD-O-3

+∞

55.6

M544, ,

ICD-10 Finland

Lumbago with sciatica

+∞

54.6

JN4BD, ,

ICD-O-3

+∞

54.6

R07, ,

ICD-O-3

+∞

54.6

G459, ,

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

+∞

54.6

SPAT1197, ,

ICD-O-3

+∞

54.6

R876, ,

ICD-10 Finland

Abnormal findings in specimens from female genital organs, abnormal cytological findings

+∞

54.6

Z208, ,

ICD-O-3

+∞

54.6

R31, ,

ICD-10 Finland

Unspecified haematuria

+∞

54.6

R065, ,

ICD-10 Finland

Mouth breathing

+∞

54.6

NGD05, ,

ICD-O-3

+∞

54.6

A01, ,

ICD-O-3

+∞

54.6

TFP34, ,

ICD-O-3

+∞

54.6

GD1AD, ,

ICD-O-3

+∞

54.6

R5180, ,

ICD-O-3

+∞

54.6

G04BD12, ,

ATC

mirabegron; oral

+∞

54.6

-31, ,

ICD-O-3

+∞

54.6

M179, ,

ICD-O-3

+∞

54.6

K04, ,

ICD-O-3

+∞

54.6

A44, ,

ICD-O-3

+∞

54.6

Z011, ,

ICD-O-3

+∞

54.6

ZY010, ,

ICD-O-3

+∞

53.5

M511, ,

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

+∞

53.5

B01AB10, ,

ATC

tinzaparin; parenteral

+∞

53.5

Z033, ,

ICD-10 Finland

Observation for suspected nervous system disorder

+∞

53.5

HA1AE, ,

ICD-O-3

+∞

53.5

XFE00, ,

ICD-O-3

+∞

53.5

G560, ,

ICD-10 Finland

Carpal tunnel syndrome

+∞

53.5

WYA10, ,

ICD-O-3

+∞

53.5

P29, ,

ICD-O-3

+∞

53.5

Z302, ,

ICD-10 Finland

Sterilization

+∞

53.5

I634, ,

ICD-10 Finland

Cerebral infarction due to embolism of cerebral arteries

+∞

53.5

T810, ,

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

+∞

53.5

S0251, ,

ICD-O-3

+∞

53.5

F3210, ,

ICD-10 Finland

Moderate depressive episode without somatic syndrome

+∞

53.5

G442, ,

ICD-10 Finland

Tension-type headache

+∞

53.5

R03BB04, ,

ATC

tiotropium bromide; inhalant

+∞

52.4

G03DC02, ,

ATC

norethisterone; oral

+∞

52.4

A05, ,

ICD-O-3

+∞

52.4

N03AG01, ,

ATC

valproic acid; systemic, rectal

+∞

52.4

E7801, ,

ICD-O-3

+∞

52.4

D509, ,

ICD-10 Finland

Iron deficiency anaemia, unspecified

+∞

52.4

S525, ,

ICD-10 Finland

Fracture of lower end of radius

+∞

52.4

SGA03, ,

ICD-O-3

+∞

52.4

Z108, ,

ICD-O-3

+∞

52.4

G431, ,

ICD-O-3

+∞

52.4

L030, ,

ICD-O-3

+∞

52.4

I482, ,

ICD-10 Finland

Chronic atrial fibrillation

+∞

52.4

FPE20, ,

ICD-O-3

+∞

52.4

S934, ,

ICD-10 Finland

Sprain and strain of ankle

+∞

51.4

OAA62, ,

ICD-O-3

+∞

51.4

SPAT1379, ,

ICD-O-3

+∞

51.4

UJF45, ,

ICD-O-3

+∞

51.4

XF640, ,

ICD-O-3

+∞

51.4

Z392, ,

ICD-O-3

+∞

51.4

R568, ,

ICD-10 Finland

Other and unspecified convulsions

+∞

51.4

SPAT1058, ,

ICD-O-3

+∞

51.4

K051, ,

ICD-O-3

+∞

51.4

A02BC04, ,

ATC

rabeprazole; oral

+∞

51.4

C03AA03, ,

ATC

hydrochlorothiazide; oral

+∞

51.4

I839, ,

ICD-10 Finland

Varicose veins of lower extremities without ulcer or inflammation

+∞

51.4

K210, ,

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

+∞

51.4

D10BA01, ,

ATC

isotretinoin; oral

+∞

51.4

K0518, ,

ICD-O-3

+∞

51.4

Z018, ,

ICD-O-3

+∞

51.4

A10BK03, ,

ATC

empagliflozin; oral

+∞

51.4

N06CA01, ,

ATC

amitriptyline and psycholeptics; systemic

+∞

50.3

N920, ,

ICD-10 Finland

Excessive and frequent menstruation with regular cycle

+∞

50.3

U01, ,

ICD-O-3

+∞

50.3

S04, ,

ICD-O-3

+∞

50.3

N05BA12, ,

ATC

alprazolam; oral

+∞

50.3

WX400, ,

ICD-O-3

+∞

50.3

DM1QA, ,

ICD-O-3

+∞

50.3

OAB39, ,

ICD-O-3

+∞

50.3

F329, ,

ICD-O-3

+∞

49.3

J320, ,

ICD-10 Finland

Chronic maxillary sinusitis

+∞

49.3

K0300, ,

ICD-O-3

+∞

49.3

I872, ,

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

+∞

49.3

C09CA03, ,

ATC

valsartan; oral

+∞

49.3

R620, ,

ICD-10 Finland

Delayed milestone

+∞

49.3

A01AB09, ,

ATC

miconazole; local oral

+∞

49.3

ZXE02, ,

ICD-O-3

+∞

49.3

R600, ,

ICD-O-3

+∞

49.3

SPAT1053, ,

ICD-O-3

+∞

49.3

Z1388, ,

ICD-O-3

+∞

49.3

M232, ,

ICD-10 Finland

Derangement of meniscus due to old tear or injury

+∞

49.3

C01BC04, ,

ATC

flecainide; systemic

+∞

49.3

R070, ,

ICD-O-3

+∞

49.3

5253, ,

ICD-O-3

+∞

49.3

L04, ,

ICD-O-3

+∞

49.3

Z039, ,

ICD-O-3

+∞

49.3

61, ,

ICD-O-3

+∞

48.2

C07AB03, ,

ATC

atenolol; systemic

+∞

48.2

I341, ,

ICD-10 Finland

Mitral (valve) prolapse

+∞

48.2

M549, ,

ICD-O-3

+∞

48.2

L14, ,

ICD-O-3

+∞

48.2

J01MA14, ,

ATC

moxifloxacin; systemic

+∞

48.2

ZXE13, ,

ICD-O-3

+∞

48.2

K30, ,

ICD-O-3

+∞

48.2

R01AD05, ,

ATC

budesonide; nasal

+∞

48.2

R529, ,

ICD-O-3

+∞

48.2

NG1BG, ,

ICD-O-3

+∞

48.2

D259, ,

ICD-10 Finland

Leiomyoma of uterus, unspecified

+∞

48.2

SJB00, ,

ICD-O-3

+∞

48.2

N06AA09, ,

ATC

amitriptyline; systemic

+∞

48.2

E6601, ,

ICD-10 Finland

Obesity due to excess calories

+∞

48.2

HA1AA, ,

ICD-O-3

+∞

48.2

Z012, ,

ICD-10 Finland

Dental examination

+∞

48.2

M17, ,

ICD-O-3

+∞

47.2

R229, ,

ICD-O-3

+∞

47.2

Z304, ,

ICD-O-3

+∞

47.2

I501, ,

ICD-10 Finland

Left ventricular failure

+∞

47.2

L04AX03, ,

ATC

methotrexate; systemic

+∞

47.2

MA1AE, ,

ICD-O-3

+∞

47.2

Z961, ,

ICD-10 Finland

Presence of intraocular lens

+∞

47.2

N06AX12, ,

ATC

bupropion; oral

+∞

47.2

N30, ,

ICD-O-3

+∞

47.2

SXA20, ,

ICD-O-3

+∞

47.2

SJC10, ,

ICD-O-3

+∞

47.2

E000006, ,

ATC

+∞

46.1

U071, ,

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

+∞

46.1

M161, ,

ICD-10 Finland

Other primary coxarthrosis

+∞

46.1

N06BA04, ,

ATC

methylphenidate; oral

+∞

46.1

A10BK01, ,

ATC

dapagliflozin; oral

+∞

46.1

M01AB08, ,

ATC

etodolac; oral

+∞

46.1

N04BC05, ,

ATC

pramipexole; oral

+∞

46.1

QAE10, ,

ICD-O-3

+∞

46.1

K0531, ,

ICD-O-3

+∞

46.1

SPAT1360, ,

ICD-O-3

+∞

46.1

A10AE04, ,

ATC

insulin glargine; parenteral

+∞

46.1

Q219, ,

ICD-10 Finland

Congenital malformation of cardiac septum, unspecified

+∞

46.1

XCK10, ,

ICD-O-3

+∞

46.1

F419, ,

ICD-10 Finland

Anxiety disorder, unspecified

+∞

46.1

M171, ,

ICD-O-3

+∞

46.1

M530, ,

ICD-O-3

+∞

45.0

F322, ,

ICD-10 Finland

Severe depressive episode without psychotic symptoms

+∞

45.0

C01CA24, ,

ATC

epinephrine; parenteral

+∞

45.0

M513, ,

ICD-10 Finland

Other specified intervertebral disc degeneration

+∞

45.0

81, ,

ICD-O-3

+∞

45.0

K007, ,

ICD-O-3

+∞

45.0

K0408, ,

ICD-O-3

+∞

45.0

G01AF01, ,

ATC

metronidazole; vaginal

+∞

45.0

C08CA02, ,

ATC

felodipine; oral

+∞

45.0

D02AX, ,

ATC

Other emollients and protectives

+∞

45.0

R002, ,

ICD-10 Finland

Palpitations

+∞

45.0

E039, ,

ICD-10 Finland

Hypothyroidism, unspecified

+∞

45.0

R073, ,

ICD-10 Finland

Other chest pain

+∞

45.0

Z713, ,

ICD-10 Finland

Dietary counselling and surveillance

+∞

45.0

K0532, ,

ICD-O-3

+∞

45.0

N02BF01, ,

ATC

gabapentin; oral

+∞

45.0

Z027, ,

ICD-O-3

+∞

45.0

Q250, ,

ICD-10 Finland

Patent ductus arteriosus

+∞

44.0

A10AC01, ,

ATC

insulin (human); parenteral

+∞

44.0

SPAT1229, ,

ICD-O-3

+∞

44.0

R09, ,

ICD-O-3

+∞

44.0

Q251, ,

ICD-10 Finland

Coarctation of aorta

+∞

44.0

I350, ,

ICD-10 Finland

Aortic (valve) stenosis

+∞

44.0

NK4XE, ,

ICD-O-3

+∞

44.0

SXB00, ,

ICD-O-3

+∞

44.0

OAA41, ,

ICD-O-3

+∞

44.0

J039, ,

ICD-10 Finland

Acute tonsillitis, unspecified

+∞

44.0

OAB95, ,

ICD-O-3

+∞

44.0

XX3BT, ,

ICD-O-3

+∞

44.0

K081, ,

ICD-O-3

+∞

44.0

N921, ,

ICD-10 Finland

Excessive and frequent menstruation with irregular cycle

+∞

44.0

-44, ,

ICD-O-3

+∞

44.0

SPAT1381, ,

ICD-O-3

+∞

44.0

TNX10, ,

ICD-O-3

+∞

42.9

62, ,

ICD-O-3

+∞

42.9

I491, ,

ICD-10 Finland

Atrial premature depolarization

+∞

42.9

RD210, ,

ICD-O-3

+∞

42.9

D02AE01, ,

ATC

carbamide; topical

+∞

42.9

P01BA02, ,

ATC

hydroxychloroquine; oral

+∞

42.9

Q221, ,

ICD-10 Finland

Congenital pulmonary valve stenosis

+∞

42.9

I269, ,

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

+∞

42.9

Q2311, ,

ICD-10 Finland

Bicuspid aortic valve

+∞

42.9

WX306, ,

ICD-O-3

+∞

42.9

V252A, ,

ICD-9 Finland

Contraceptive management, Sterilisation

+∞

42.9

H02AB02, ,

ATC

dexamethasone; systemic

+∞

42.9

R073, ,

ICD-O-3

+∞

42.9

SDA05, ,

ICD-O-3

+∞

42.9

MAX99, ,

ICD-O-3

+∞

42.9

M05BA04, ,

ATC

alendronic acid; oral

+∞

42.9

K0522, ,

ICD-O-3

+∞

41.9

F02, ,

ICD-O-3

+∞

41.9

H103, ,

ICD-O-3

+∞

41.9

W22, ,

ICD-10 Finland

Striking against or struck by other object(s)

+∞

41.9

SPAT1380, ,

ICD-O-3

+∞

41.9

H109, ,

ICD-O-3

+∞

41.9

G01AF05, ,

ATC

econazole; vaginal

+∞

41.9

R11, ,

ICD-10 Finland

Nausea and vomiting

+∞

41.9

SPAT1104, ,

ICD-O-3

+∞

41.9

SHA02, ,

ICD-O-3

+∞

41.9

R2110, ,

ICD-O-3

+∞

41.9

TKC20, ,

ICD-O-3

+∞

41.9

CJB10, ,

ICD-O-3

+∞

41.9

OAB93, ,

ICD-O-3

+∞

41.9

M722, ,

ICD-O-3

+∞

41.9

H920, ,

ICD-O-3

+∞

41.9

R600, ,

ICD-10 Finland

Localized oedema

+∞

41.9

Z637, ,

ICD-10 Finland

Other stressful life events affecting family and household

+∞

41.9

K359, ,

ICD-10 Finland

Acute appendicitis, unspecified

+∞

41.9

Z349, ,

ICD-10 Finland

Supervision of normal pregnancy, unspecified

+∞

40.8

I481, ,

ICD-10 Finland

Persistent atrial fibrillation

+∞

40.8

Z251, ,

ICD-O-3

+∞

40.8

N760, ,

ICD-O-3

+∞

40.8

SJX10, ,

ICD-O-3

+∞

40.8

N40, ,

ICD-10 Finland

Hyperplasia of prostate

+∞

40.8

B349, ,

ICD-10 Finland

Viral infection, unspecified

+∞

40.8

U07, ,

ICD-O-3

+∞

40.8

WX720, ,

ICD-O-3

+∞

40.8

SJX11, ,

ICD-O-3

+∞

40.8

I251, ,

ICD-O-3

+∞

40.8

L84, ,

ICD-O-3

+∞

39.8

C01BD01, ,

ATC

amiodarone; systemic

+∞

39.8

GD1DD, ,

ICD-O-3

+∞

39.8

R01AD11, ,

ATC

triamcinolone; nasal

+∞

39.8

S22, ,

ICD-O-3

+∞

39.8

602, ,

Kela drug reimbursment

Children's severe malnutrition

+∞

39.8

U072, ,

ICD-10 Finland

COVID-19, virus not identified

+∞

39.8

E785, ,

ICD-10 Finland

Hyperlipidaemia, unspecified

+∞

39.8

NC1AA, ,

ICD-O-3

+∞

39.8

Z321, ,

ICD-10 Finland

Pregnancy confirmed

+∞

39.8

GD1BD, ,

ICD-O-3

+∞

39.8

J01CF05, ,

ATC

flucloxacillin; systemic

+∞

39.8

O049, ,

ICD-10 Finland

Medical abortion, complete or unspecified, without complication

+∞

39.8

OIKK, ,

ICD-O-3

+∞

39.8

J029, ,

ICD-O-3

+∞

39.8

F900, ,

ICD-10 Finland

Disturbance of activity and attention

+∞

39.8

A07EC01, ,

ATC

sulfasalazine; oral, rectal

+∞

39.8

SPAT1255, ,

ICD-O-3

+∞

39.8

P76, ,

ICD-O-3

+∞

39.8

A10AB05, ,

ATC

insulin aspart; parenteral

+∞

39.8

SJX21, ,

ICD-O-3

+∞

39.8

115, ,

Kela drug reimbursment

Breast cancer

+∞

39.8

Q2118, ,

ICD-10 Finland

Other spedified atrial septal defect

+∞

39.8

M239, ,

ICD-O-3

+∞

39.8

WZC20, ,

ICD-O-3

+∞

39.8

H264, ,

ICD-10 Finland

After-cataract

+∞

39.8

F83, ,

ICD-10 Finland

Mixed specific developmental disorders

+∞

39.8

UDQ12, ,

ICD-O-3

+∞

39.8

DMB20, ,

ICD-O-3

+∞

39.8

N40, ,

ICD-O-3

+∞

38.7

J310, ,

ICD-10 Finland

Chronic rhinitis

+∞

38.7

R062, ,

ICD-10 Finland

Wheezing

+∞

38.7

K0725, ,

ICD-O-3

+∞

38.7

K86, ,

ICD-O-3

+∞

38.7

M170, ,

ICD-O-3

+∞

38.7

APK, ,

ICD-O-3

+∞

38.7

SPAT1389, ,

ICD-O-3

+∞

38.7

D09, ,

ICD-O-3

+∞

38.7

K044, ,

ICD-O-3

+∞

38.7

D01AC03, ,

ATC

econazole; topical

+∞

38.7

S02CA02, ,

ATC

flumetasone and antiinfectives; otic

+∞

38.7

SJD00, ,

ICD-O-3

+∞

38.7

EMB10, ,

ICD-O-3

+∞

38.7

Z090, ,

ICD-10 Finland

Follow-up examination after surgery for other conditions

+∞

38.7

J350, ,

ICD-10 Finland

Chronic tonsillitis

+∞

38.7

WX307, ,

ICD-O-3

+∞

38.7

TNX33, ,

ICD-O-3

+∞

38.7

SCF02, ,

ICD-O-3

+∞

38.7

R03AK10, ,

ATC

vilanterol and fluticasone furoate; inhalant

+∞

38.7

PA6DE, ,

ICD-O-3

+∞

38.7

JN3AA, ,

ICD-O-3

+∞

37.7

I3400, ,

ICD-10 Finland

Mitral (valve) incompetence NOS or of specified cause, except rheumatic

+∞

37.7

74639, ,

ICD-8 Finland

Congenital anomalies of heart, Defectus septi ventriculorum

+∞

37.7

I2081, ,

ICD-10 Finland

Other angina pectoris stenosed coronary artery

+∞

37.7

H531, ,

ICD-10 Finland

Subjective visual disturbances

+∞

37.7

FFC50, ,

ICD-O-3

+∞

37.7

SJC50, ,

ICD-O-3

+∞

37.7

NJ2MA, ,

ICD-O-3

+∞

37.7

L10, ,

ICD-O-3

+∞

37.7

H66, ,

ICD-O-3

+∞

37.7

S01, ,

ICD-O-3

+∞

37.7

I693, ,

ICD-O-3

+∞

37.7

A10BH01, ,

ATC

sitagliptin; oral

+∞

37.7

SPAT1144, ,

ICD-O-3

+∞

37.7

SAD02, ,

ICD-O-3

+∞

37.7

C09DA01, ,

ATC

losartan and diuretics; oral

+∞

37.7

Z719, ,

ICD-O-3

+∞

37.7

J040, ,

ICD-10 Finland

Acute laryngitis

+∞

37.7

I480, ,

ICD-O-3

+∞

37.7

R418, ,

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

+∞

37.7

NGB20, ,

ICD-O-3

+∞

37.7

FP1B5, ,

ICD-O-3

+∞

37.7

WZC10, ,

ICD-O-3

+∞

37.7

N03AX09, ,

ATC

lamotrigine; oral

+∞

37.7

A04AA01, ,

ATC

ondansetron; systemic, rectal

+∞

37.7

SPAT1028, ,

ICD-O-3

+∞

37.7

Z769, ,

ICD-10 Finland

Person encountering health services in unspecified circumstances

+∞

37.7

H609, ,

ICD-O-3

+∞

37.7

SJC40, ,

ICD-O-3

+∞

37.7

CK2X4, ,

ICD-O-3

+∞

37.7

R29, ,

ICD-O-3

+∞

37.7

S800, ,

ICD-O-3

+∞

37.7

L09, ,

ICD-O-3

+∞

37.7

G430, ,

ICD-10 Finland

Migraine without aura [common migraine]

+∞

37.7

N950, ,

ICD-10 Finland

Postmenopausal bleeding

+∞

37.7

WX725, ,

ICD-O-3

+∞

37.7

G43, ,

ICD-O-3

+∞

37.7

GA4YT, ,

ICD-O-3

+∞

36.6

K020, ,

ICD-10 Finland

Caries limited to enamel

+∞

36.6

NK6MA, ,

ICD-O-3

+∞

36.6

Z952, ,

ICD-10 Finland

Presence of prosthetic heart valve

+∞

36.6

K449, ,

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

+∞

36.6

TNX50, ,

ICD-O-3

+∞

36.6

SPAT1285, ,

ICD-O-3

+∞

36.6

H0410, ,

ICD-O-3

+∞

36.6

L02BG04, ,

ATC

letrozole; oral

+∞

36.6

JAB30, ,

ICD-O-3

+∞

36.6

EP1AE, ,

ICD-O-3

+∞

36.6

I442, ,

ICD-10 Finland

Atrioventricular block, complete

+∞

36.6

S12, ,

ICD-O-3

+∞

36.6

OAA64, ,

ICD-O-3

+∞

36.6

R91, ,

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

+∞

36.6

M771, ,

ICD-O-3

+∞

36.6

D01AC02, ,

ATC

miconazole; topical

+∞

36.6

TFC99, ,

ICD-O-3

+∞

36.6

R4130, ,

ICD-O-3

+∞

36.6

Z113, ,

ICD-10 Finland

Special screening examination for infections with a predominantly sexual mode of transmission

+∞

36.6

LDA20, ,

ICD-O-3

+∞

36.6

N394, ,

ICD-10 Finland

Other specified urinary incontinence

+∞

36.6

E03, ,

ICD-O-3

+∞

36.6

O8210, ,

ICD-10 Finland

Delivery by emergency caesarean section

+∞

36.6

F458, ,

ICD-O-3

+∞

36.6

K429, ,

ICD-10 Finland

Umbilical hernia without obstruction or gangrene

+∞

36.6

N05BB01, ,

ATC

hydroxyzine; systemic

+∞

36.6

IGY99, ,

ICD-O-3

+∞

36.6

Z3232, ,

ICD-O-3

+∞

36.6

K083, ,

ICD-O-3

+∞

35.6

F412, ,

ICD-10 Finland

Mixed anxiety and depressive disorder

+∞

35.6

J01, ,

ICD-O-3

+∞

35.6

OAA30, ,

ICD-O-3

+∞

35.6

M480, ,

ICD-10 Finland

Spinal stenosis

+∞

35.6

Z340, ,

ICD-10 Finland

Supervision of normal first pregnancy

+∞

35.6

D02, ,

ICD-O-3

+∞

35.6

R51, ,

ICD-O-3

+∞

35.6

R1100, ,

ICD-O-3

+∞

35.6

M201, ,

ICD-10 Finland

Hallux valgus (acquired)

+∞

35.6

PJA12, ,

ICD-O-3

+∞

35.6

JFA15, ,

ICD-O-3

+∞

35.6

M546, ,

ICD-O-3

+∞

35.6

ZXE40, ,

ICD-O-3

+∞

35.6

ICB01, ,

ICD-O-3

+∞

35.6

B01AE07, ,

ATC

dabigatran etexilate; oral

+∞

35.6

H0410, ,

ICD-10 Finland

Dry eye syndrome

+∞

35.6

K22, ,

ICD-O-3

+∞

35.6

J22, ,

ICD-O-3

+∞

35.6

C09CA07, ,

ATC

telmisartan; oral

+∞

35.6

WX000, ,

ICD-O-3

+∞

35.6

EBA15, ,

ICD-O-3

+∞

35.6

C10AA03, ,

ATC

pravastatin; oral

+∞

35.6

SGA05, ,

ICD-O-3

+∞

35.6

U71, ,

ICD-O-3

+∞

35.6

N02CC03, ,

ATC

zolmitriptan; nasal, oral

+∞

35.6

H520, ,

ICD-10 Finland

Hypermetropia

+∞

35.6

Y83, ,

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

+∞

35.6

104, ,

Kela drug reimbursment

Thyroid insufficiency

+∞

35.6

D01AE15, ,

ATC

terbinafine; topical

+∞

35.6

TQW99, ,

ICD-O-3

+∞

35.6

AA5HE, ,

ICD-O-3

+∞

35.6

D229, ,

ICD-O-3

+∞

34.5

Q2120, ,

ICD-10 Finland

Atrial septal defect of primum type

+∞

34.5

Z300, ,

ICD-O-3

+∞

34.5

A07AA02, ,

ATC

nystatin; oral

+∞

34.5

R03AK08, ,

ATC

formoterol and beclometasone; inhalant

+∞

34.5

I259, ,

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

+∞

34.5

XG410, ,

ICD-O-3

+∞

34.5

H811, ,

ICD-10 Finland

Benign paroxysmal vertigo

+∞

34.5

SPAT1303, ,

ICD-O-3

+∞

34.5

M549, ,

ICD-10 Finland

Dorsalgia, unspecified

+∞

34.5

JEA00, ,

ICD-O-3

+∞

34.5

SPAT1215, ,

ICD-O-3

+∞

34.5

SPAT1364, ,

ICD-O-3

+∞

34.5

O244, ,

ICD-10 Finland

Diabetes mellitus arising in pregnancy

+∞

34.5

Q211, ,

ICD-10 Finland

Atrial septal defect

+∞

34.5

N63, ,

ICD-O-3

+∞

34.5

MA3AE, ,

ICD-O-3

+∞

34.5

SJC03, ,

ICD-O-3

+∞

34.5

M170, ,

ICD-10 Finland

Primary gonarthrosis, bilateral

+∞

34.5

OAA11, ,

ICD-O-3

+∞

34.5

H03BB01, ,

ATC

carbimazole; oral

+∞

34.5

SJD10, ,

ICD-O-3

+∞

34.5

WX722, ,

ICD-O-3

+∞

34.5

R13, ,

ICD-10 Finland

Dysphagia

+∞

34.5

ZXD31, ,

ICD-O-3

+∞

33.5

A48, ,

ICD-O-3

+∞

33.5

Z208, ,

ICD-10 Finland

Contact with and exposure to other communicable diseases

+∞

33.5

AF1, ,

ICD-O-3

+∞

33.5

H612, ,

ICD-O-3

+∞

33.5

N06AB05, ,

ATC

paroxetine; oral

+∞

33.5

R040, ,

ICD-O-3

+∞

33.5

SCF01, ,

ICD-O-3

+∞

33.5

G03DA02, ,

ATC

medroxyprogesterone; systemic

+∞

33.5

IGY02, ,

ICD-O-3

+∞

33.5

W14, ,

ICD-O-3

+∞

33.5

F3310, ,

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

+∞

33.5

D649, ,

ICD-O-3

+∞

33.5

N840, ,

ICD-10 Finland

Polyp of corpus uteri

+∞

33.5

R12, ,

ICD-O-3

+∞

33.5

B01AB04, ,

ATC

dalteparin; parenteral

+∞

33.5

R05DA01, ,

ATC

ethylmorphine; oral

+∞

33.5

E000007, ,

ATC

+∞

33.5

M674, ,

ICD-10 Finland

Ganglion

+∞

33.5

A419, ,

ICD-10 Finland

Sepsis, unspecified

+∞

33.5

ACC51, ,

ICD-O-3

+∞

33.5

S06, ,

ICD-O-3

+∞

33.5

K05, ,

ICD-O-3

+∞

33.5

K0723, ,

ICD-O-3

+∞

33.5

S97, ,

ICD-O-3

+∞

33.5

L20, ,

ICD-O-3

+∞

33.5

Z209, ,

ICD-10 Finland

Contact with and exposure to unspecified communicable disease

+∞

33.5

M190, ,

ICD-10 Finland

Primary arthrosis of other joints

+∞

32.4

G439, ,

ICD-10 Finland

Migraine, unspecified

+∞

32.4

P02, ,

ICD-O-3

+∞

32.4

TDA90, ,

ICD-O-3

+∞

32.4

X02, ,

ICD-O-3

+∞

32.4

N89, ,

ICD-O-3

+∞

32.4

Z360, ,

ICD-10 Finland

Antenatal screening for chromosomal anomalies

+∞

32.4

H811, ,

ICD-O-3

+∞

32.4

K0380, ,

ICD-O-3

+∞

32.4

F321, ,

ICD-O-3

+∞

32.4

S010, ,

ICD-10 Finland

Open wound of scalp

+∞

32.4

74663, ,

ICD-8 Finland

Congenital anomalies of heart, Stenosis valvulae pulmonalis

+∞

32.4

X23, ,

ICD-O-3

+∞

32.4

F430, ,

ICD-O-3

+∞

32.4

N05AH03, ,

ATC

olanzapine; systemic

+∞

32.4

W17, ,

ICD-10 Finland

Other fall from one level to another

+∞

32.4

P22, ,

ICD-O-3

+∞

32.4

TDM10, ,

ICD-O-3

+∞

32.4

XF622, ,

ICD-O-3

+∞

32.4

K921, ,

ICD-10 Finland

Melaena

+∞

32.4

H010, ,

ICD-O-3

+∞

32.4

G03FB06, ,

ATC

medroxyprogesterone and estrogen; systemic

+∞

32.4

XPX99, ,

ICD-O-3

+∞

32.4

TNX32, ,

ICD-O-3

+∞

32.4

MA5AE, ,

ICD-O-3

+∞

32.4

N02BF02, ,

ATC

pregabalin; oral

+∞

32.4

R002, ,

ICD-O-3

+∞

32.4

J3010, ,

ICD-10 Finland

Allergic rhinitis due to pollen

+∞

32.4

R75, ,

ICD-O-3

+∞

32.4

QDB10, ,

ICD-O-3

+∞

32.4

N02CC04, ,

ATC

rizatriptan; oral

+∞

32.4

O342, ,

ICD-10 Finland

Maternal care due to uterine scar from previous surgery

+∞

32.4

Z461, ,

ICD-10 Finland

Fitting and adjustment of hearing aid

+∞

31.4

SJC01, ,

ICD-O-3

+∞

31.4

SPAT1213, ,

ICD-O-3

+∞

31.4

1412, ,

ICD-O-3

+∞

31.4

A08, ,

ICD-O-3

+∞

31.4

SPAT1224, ,

ICD-O-3

+∞

31.4

M139, ,

ICD-10 Finland

Arthritis, unspecified

+∞

31.4

F32, ,

ICD-O-3

+∞

31.4

A92, ,

ICD-O-3

+∞

31.4

G03CA04, ,

ATC

estriol; systemic, vaginal

+∞

31.4

I420, ,

ICD-10 Finland

Dilated cardiomyopathy

+∞

31.4

C08DB01, ,

ATC

diltiazem; oral

+∞

31.4

G04CA01, ,

ATC

alfuzosin; oral

+∞

31.4

NA1BG, ,

ICD-O-3

+∞

31.4

R06AX26, ,

ATC

fexofenadine; oral

+∞

31.4

46599, ,

ICD-8 Finland

Acute upper respiratory infection of multiple or unspecified sites

+∞

31.4

P24, ,

ICD-O-3

+∞

31.4

P073, ,

ICD-10 Finland

Other preterm infants

+∞

31.4

R202, ,

ICD-10 Finland

Paraesthesia of skin

+∞

31.4

MA2XE, ,

ICD-O-3

+∞

31.4

NH3BA, ,

ICD-O-3

+∞

31.4

F101, ,

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

+∞

31.4

SPAT1252, ,

ICD-O-3

+∞

31.4

L05, ,

ICD-O-3

+∞

31.4

A07EC02, ,

ATC

mesalazine; oral, rectal

+∞

31.4

ZXM10, ,

ICD-O-3

+∞

31.4

-30, ,

ICD-O-3

+∞

31.4

K580, ,

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

+∞

31.4

O470, ,

ICD-10 Finland

False labour before 37 completed weeks of gestation

+∞

31.4

H438, ,

ICD-10 Finland

Other disorders of vitreous body

+∞

31.4

112, ,

Kela drug reimbursment

Severe psychotic and other severe mental disorders

+∞

31.4

J02, ,

ICD-O-3

+∞

31.4

PA7AD, ,

ICD-O-3

+∞

31.4

TLC02, ,

ICD-O-3

+∞

31.4

JHB30, ,

ICD-O-3

+∞

31.4

F510, ,

ICD-10 Finland

Nonorganic insomnia

+∞

31.4

LC2DE, ,

ICD-O-3

+∞

30.3

CK2S4, ,

ICD-O-3

+∞

30.3

M75, ,

ICD-O-3

+∞

30.3

F411, ,

ICD-10 Finland

Generalized anxiety disorder

+∞

30.3

S15, ,

ICD-O-3

+∞

30.3

S060, ,

ICD-O-3

+∞

30.3

F332, ,

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

+∞

30.3

TAB00, ,

ICD-O-3

+∞

30.3

S826, ,

ICD-10 Finland

Fracture of lateral malleolus

+∞

30.3

R03AC13, ,

ATC

formoterol; inhalant

+∞

30.3

J01MA01, ,

ATC

ofloxacin; systemic

+∞

30.3

114, ,

Kela drug reimbursment

Glaucoma

+∞

30.3

I2099, ,

ICD-10 Finland

Angina pectoris, unspecified

+∞

30.3

RS221, ,

ICD-O-3

+∞

30.3

S01GX02, ,

ATC

levocabastine; ophthalmic

+∞

30.3

504, ,

Kela drug reimbursment

Conditions requiring daily forced enteral nutrition

+∞

30.3

D225, ,

ICD-O-3

+∞

30.3

D126, ,

ICD-10 Finland

Benign neoplasm: Colon, unspecified

+∞

30.3

TFB00, ,

ICD-O-3

+∞

30.3

Z298, ,

ICD-O-3

+∞

30.3

W10, ,

ICD-10 Finland

Fall on and from stairs and steps

+∞

30.3

R010, ,

ICD-10 Finland

Benign and innocent cardiac murmurs

+∞

30.3

LC2HE, ,

ICD-O-3

+∞

30.3

I872, ,

ICD-O-3

+∞

30.3

R11, ,

ICD-O-3

+∞

30.3

G409, ,

ICD-10 Finland

Epilepsy, unspecified

+∞

30.3

S02, ,

ICD-O-3

+∞

30.3

R000, ,

ICD-10 Finland

Tachycardia, unspecified

+∞

30.3

FM1CG, ,

ICD-O-3

+∞

30.3

S01AA01, ,

ATC

chloramphenicol; ophthalmic

+∞

29.3

6350C, ,

ICD-9 Finland

Legally induced abortion, Complicated by genital tract and pelvic infection[ABORTUS PROV LEGAL SINE COMPL,SOSIAALISET SYYT]

+∞

29.3

TEW99, ,

ICD-O-3

+∞

29.3

D22, ,

ICD-O-3

+∞

29.3

J06, ,

ICD-O-3

+∞

29.3

GA1AE, ,

ICD-O-3

+∞

29.3

S610, ,

ICD-O-3

+∞

29.3

N816, ,

ICD-10 Finland

Rectocele

+∞

29.3

J01EE01, ,

ATC

sulfamethoxazole and trimethoprim; systemic

+∞

29.3

J352, ,

ICD-10 Finland

Hypertrophy of adenoids

+∞

29.3

NE1AA, ,

ICD-O-3

+∞

29.3

NF1AE, ,

ICD-O-3

+∞

29.3

OAB47, ,

ICD-O-3

+∞

29.3

N952, ,

ICD-O-3

+∞

29.3

C08DA01, ,

ATC

verapamil; systemic

+∞

29.3

C03EB01, ,

ATC

furosemide and potassium-sparing agents; systemic

+∞

29.3

N02CC07, ,

ATC

frovatriptan; oral

+∞

29.3

MA2JE, ,

ICD-O-3

+∞

29.3

ICZ03, ,

ICD-O-3

+∞

29.3

Z71, ,

ICD-O-3

+∞

29.3

SPAT1190, ,

ICD-O-3

+∞

29.3

Z305, ,

ICD-O-3

+∞

29.3

DM1AA, ,

ICD-O-3

+∞

29.3

E109, ,

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

+∞

29.3

N926, ,

ICD-10 Finland

Irregular menstruation, unspecified

+∞

29.3

PG1DE, ,

ICD-O-3

+∞

29.3

H02AB09, ,

ATC

hydrocortisone; systemic

+∞

29.3

QBE10, ,

ICD-O-3

+∞

29.3

I441, ,

ICD-10 Finland

Atrioventricular block, second degree

+∞

29.3

J448, ,

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

+∞

29.3

H530, ,

ICD-10 Finland

Amblyopia ex anopsia

+∞

29.3

M01AB01, ,

ATC

indometacin; systemic, rectal

+∞

29.3

M02AA15, ,

ATC

diclofenac; topical

+∞

29.3

D500, ,

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

+∞

29.3

XMA22, ,

ICD-O-3

+∞

29.3

WX702, ,

ICD-O-3

+∞

29.3

Z348, ,

ICD-O-3

+∞

29.3

E66, ,

ICD-O-3

+∞

29.3

H521, ,

ICD-10 Finland

Myopia

+∞

29.3

Z876, ,

ICD-10 Finland

Personal history of certain conditions arising in the perinatal period

+∞

29.3

H522, ,

ICD-10 Finland

Astigmatism

+∞

29.3

NFB30, ,

ICD-O-3

+∞

29.3

H01AC01, ,

ATC

somatropin; parenteral

+∞

28.2

UJD02, ,

ICD-O-3

+∞

28.2

Z301, ,

ICD-10 Finland

Insertion of (intrauterine) contraceptive device

+∞

28.2

WW500, ,

ICD-O-3

+∞

28.2

K07, ,

ICD-O-3

+∞

28.2

ZXE15, ,

ICD-O-3

+∞

28.2

A06AC51, ,

ATC

ispaghula, combinations; oral

+∞

28.2

K30, ,

ICD-10 Finland

Functional dyspepsia

+∞

28.2

I842, ,

ICD-10 Finland

Internal hemorrhoids without complication

+∞

28.2

S800, ,

ICD-10 Finland

Contusion of knee

+∞

28.2

K5909, ,

ICD-10 Finland

Constipation, unspecified

+∞

28.2

XCK00, ,

ICD-O-3

+∞

28.2

IHZ05, ,

ICD-O-3

+∞

28.2

J2190, ,

ICD-10 Finland

Acute obstructive bronchitis in children

+∞

28.2

R1230, ,

ICD-O-3

+∞

28.2

K21, ,

ICD-O-3

+∞

28.2

IDY03, ,

ICD-O-3

+∞

28.2

F339, ,

ICD-10 Finland

Recurrent depressive disorder, unspecified

+∞

28.2

K84, ,

ICD-O-3

+∞

28.2

I633, ,

ICD-10 Finland

Cerebral infarction due to thrombosis of cerebral arteries

+∞

28.2

45499, ,

ICD-8 Finland

Varicose veins of lower extremities, Other and unspecified, without ulcer

+∞

28.2

SPAT1196, ,

ICD-O-3

+∞

28.2

K573, ,

ICD-O-3

+∞

28.2

Z501, ,

ICD-10 Finland

Other physical therapy

+∞

28.2

RS224, ,

ICD-O-3

+∞

28.2

A12BA01, ,

ATC

potassium chloride; oral

+∞

28.2

H60, ,

ICD-O-3

+∞

28.2

AA1DG, ,

ICD-O-3

+∞

28.2

A77, ,

ICD-O-3

+∞

28.2

SPAT1081, ,

ICD-O-3

+∞

28.2

M10, ,

ICD-O-3

+∞

28.2

IAZ97, ,

ICD-O-3

+∞

28.2

D06BB04, ,

ATC

podophyllotoxin; topical

+∞

28.2

N07CA01, ,

ATC

betahistine; oral

+∞

28.2

ULC02, ,

ICD-O-3

+∞

28.2

JAH01, ,

ICD-O-3

+∞

28.2

A02BA04, ,

ATC

nizatidine; systemic

+∞

28.2

SPAT1295, ,

ICD-O-3

+∞

28.2

74646, ,

ICD-8 Finland

Congenital anomalies of heart, Defectus septi atriorum, ostium primum

+∞

28.2

H0000, ,

ICD-O-3

+∞

28.2

S01GX08, ,

ATC

ketotifen; ophthalmic

+∞

27.2

I702, ,

ICD-10 Finland

Atherosclerosis of arteries of extremities

+∞

27.2

Z003, ,

ICD-O-3

+∞

27.2

EBA30, ,

ICD-O-3

+∞

27.2

Z023, ,

ICD-O-3

+∞

27.2

4273A, ,

ICD-9 Finland

Cardiac dysrhythmias, Atrial fibrillation and flutter

+∞

27.2

O814, ,

ICD-10 Finland

Vacuum extractor delivery

+∞

27.2

G451, ,

ICD-10 Finland

Carotid artery syndrome (hemispheric)

+∞

27.2

F16, ,

ICD-O-3

+∞

27.2

FPE30, ,

ICD-O-3

+∞

27.2

SPAT1059, ,

ICD-O-3

+∞

27.2

R04, ,

ICD-O-3

+∞

27.2

R01BA01, ,

ATC

phenylpropanolamine; oral

+∞

27.2

OAA10, ,

ICD-O-3

+∞

27.2

J01DC02, ,

ATC

cefuroxime; systemic

+∞

27.2

IEY05, ,

ICD-O-3

+∞

27.2

OAA81, ,

ICD-O-3

+∞

27.2

OAB91, ,

ICD-O-3

+∞

27.2

L200, ,

ICD-O-3

+∞

27.2

S525, ,

ICD-O-3

+∞

27.2

NA1AD, ,

ICD-O-3

+∞

27.2

MAE00, ,

ICD-O-3

+∞

27.2

K580, ,

ICD-O-3

+∞

27.2

N393, ,

ICD-10 Finland

Stress incontinence

+∞

27.2

K0400, ,

ICD-O-3

+∞

27.2

HA1RA, ,

ICD-O-3

+∞

27.2

G560, ,

ICD-O-3

+∞

27.2

J90, ,

ICD-10 Finland

Pleural effusion, not elsewhere classified

+∞

27.2

K591, ,

ICD-O-3

+∞

27.2

S832, ,

ICD-10 Finland

Tear of meniscus, current

+∞

27.2

Q203, ,

ICD-10 Finland

Discordant ventriculoarterial connection

+∞

27.2

H651, ,

ICD-10 Finland

Other acute nonsuppurative otitis media

+∞

27.2

F411, ,

ICD-O-3

+∞

27.2

Z370, ,

ICD-10 Finland

Single live birth

+∞

27.2

S01ED51, ,

ATC

timolol, combinations; ophthalmic

+∞

27.2

T89, ,

ICD-O-3

+∞

27.2

Z340, ,

ICD-O-3

+∞

27.2

K90, ,

ICD-O-3

+∞

27.2

P74, ,

ICD-O-3

+∞

27.2

Z988, ,

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

484

1741

4.15

115.03

5.4

3.6

1309.43

1120.87

ng/l

0.45

446

1455

(3022217) INR in Platelet poor plasma by Coagulation assay

632

3146

3.34

84.39

25.8

10.5

1.49

1.17

inr

8.22

166

942

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

209

519

4.72

78.70

3.2

4.1

198.23

200.93

ng/l

0.03

193

473

(3018677) aPTT in Platelet poor plasma by Coagulation assay

342

1339

3.24

65.43

3.2

4.0

31.03

30.17

1.51

332

1308

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

319

1377

2.84

49.49

3.8

3.6

1388.87

511.31

ng/l

1.35

257

940

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

386

2055

2.34

36.87

2.4

2.6

—

(3033658) Prothrombin time (PT) actual/Normal

409

2241

2.30

36.43

5.8

80.80

91.51

12.43

402

2190

(3044640) Blood type and Crossmatch panel - Blood

440

2620

2.12

30.66

2.6

2.7

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

264

1324

2.30

27.89

6.2

7.4

0.83

0.81

mmol/l

1.00

251

1258

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

572

3883

1.97

26.53

2.9

2.8

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

135

509

2.87

25.79

1.8

2.4

15.29

6.53

ug/l

2.56

116

447

(3044889) 12 lead EKG panel

698

5232

1.90

22.36

4.6

3.3

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

8.22

21.74

3.8

8.4

—

(3036489) Thrombin time

122

479

2.73

21.49

3.8

5.3

21.99

22.48

0.59

104

445

(3038071) Oxygen [Partial pressure] in Mixed venous blood

8.39

21.36

3.3

8.3

—

(3013512) EKG study

313

1888

1.91

19.24

5.3

3.5

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

100

382

2.77

18.52

20.8

13.6

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

660

5055

1.75

17.65

8.1

6.0

6.23

6.40

mmol/l

1.58

627

4704

(3003396) Base excess in Arterial blood by calculation

157

757

2.24

17.63

15.2

9.8

1.14

0.77

mmol/l

0.56

139

604

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

378

2514

1.76

16.43

4.4

3.2

50.77

51.33

ng/l

0.01

257

1531

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

217

3.01

14.08

10.6

10.2

0.31

0.36

u/ml

0.81

124

(3019550) Sodium [Moles/volume] in Serum or Plasma

996

8880

2.20

13.94

21.4

14.4

139.54

139.55

mmol/l

0.05

991

8653

(3000991) Gas panel - Venous blood

200

1146

1.90

13.89

14.9

10.7

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

262

2.77

13.47

2.0

2.1

1.21

1.38

g/l

0.85

231

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

12.98

13.41

2.7

2.9

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

995

8894

2.16

13.39

21.6

14.4

3.98

3.95

mmol/l

2.39

989

8641

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

322

2156

1.69

13.10

2.6

2.3

249.51

247.80

u/l

0.01

301

2052

(3024928) Oxygen saturation in Venous blood

206

2.96

12.89

5.1

12.5

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

151

812

1.99

12.58

3.6

5.0

258.60

284.30

u/l

0.57

144

778

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

190

1115

1.84

12.14

3.4

2.8

20.46

22.62

1.60

174

1005

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

520

3975

1.57

12.09

12.8

9.4

1.21

1.22

mmol/l

4.93

487

3697

(3003458) Phosphate [Moles/volume] in Serum or Plasma

229

1431

1.75

11.83

8.4

9.1

1.24

1.21

mmol/l

0.62

220

1362

(3022313) Gas panel - Capillary blood

173

994

1.87

11.80

10.2

9.3

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

157

3.14

11.74

1.2

1.1

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

159

3.10

11.50

1.3

1.2

3.53

5.93

u/ml

0.73

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

104

3.63

11.46

2.5

2.3

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

202

1233

1.77

11.28

1.9

2.0

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

193

1166

1.79

11.15

10.0

9.1

2.01

1.03

mmol/l

5.58

160

855

(3004789) Transferrin [Mass/volume] in Serum or Plasma

197

1205

1.77

10.89

3.3

2.7

2.48

2.44

g/l

0.43

186

1132

(3009343) pH of Capillary blood

194

1186

1.76

10.74

10.1

9.0

7.40

7.41

—

(3022948) Iron [Moles/volume] in Serum or Plasma

210

1318

1.73

10.59

3.3

2.7

12.59

13.65

umol/l

1.33

199

1246

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

160

2.95

10.15

1.4

1.2

1.76

4.43

u/ml

1.02

(3012441) Differential panel - Pleural fluid

4.50

10.00

1.7

1.4

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

3.71

9.97

3.2

3.1

0.82

0.86

nmol/l

0.12

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

110

3.34

9.85

1.2

1.1

98.47

93.55

0.43

103

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

518

4077

1.50

9.82

8.2

6.9

16.85

14.88

umol/l

0.79

483

3835

(3028308) Erythrocytes [#/volume] in Pleural fluid

4.74

9.74

1.9

1.3

21434.67

58156.93

e6/l

0.67

(3023368) Bacteria identified in Blood by Culture

277

1915

1.59

9.47

4.6

4.4

—

(3002032) Base excess in Venous blood by calculation

200

1278

1.68

9.36

6.4

8.7

1.59

1.42

mmol/l

0.29

170

1034

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

267

1849

1.58

9.00

3.0

2.7

1.38

1.36

mg/l

0.02

189

1396

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

539

4328

1.47

8.95

11.3

9.4

1.21

1.22

mmol/l

3.28

472

3816

(3024561) Albumin [Mass/volume] in Serum or Plasma

431

3334

1.47

8.55

5.8

6.0

36.09

36.53

g/l

0.85

404

3144

(3014111) Lactate [Moles/volume] in Serum or Plasma

136

804

1.78

8.36

18.4

10.5

1.27

1.38

mmol/l

0.50

136

785

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

122

3.01

8.35

7.3

7.5

11.46

11.12

mg/l

0.12

116

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

989

9103

1.79

8.11

17.5

12.5

23.91

21.85

mg/l

1.23

814

6803

(3027945) Reticulocytes/100 erythrocytes in Blood

164

1046

1.66

7.65

3.4

4.7

1.92

1.60

2.00

154

974

(40761511) CBC panel - Blood by Automated count

1011

9395

1.86

7.63

16.6

11.0

—

(3003694) ABO and Rh group [Type] in Blood

361

2747

1.46

7.59

1.4

1.6

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

346

2.08

7.35

1.2

1.7

—

12.66

—

(3023520) Reticulocytes [#/volume] in Blood

126

759

1.74

7.25

3.0

3.7

77.17

67.60

e9/l

1.38

524

(3011648) Oxygen content in Venous blood

111

2.93

7.16

5.9

19.2

11.58

11.29

0.27

111

(3045788) Cell count panel - Pleural fluid

4.13

6.79

1.9

1.3

—

(40768806) Pleura Pathology biopsy report

3.91

6.69

2.1

1.7

—

(3012501) Base excess in Blood by calculation

162

2.52

6.69

7.3

5.3

1.71

2.27

mmol/l

0.87

100

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

143

911

1.65

6.68

1.9

2.0

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

141

905

1.63

6.40

1.9

—

(3042936) Bacteria identified in Isolate by Culture

167

1120

1.57

6.31

2.5

2.0

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

563

1.77

6.08

2.8

2.9

63.85

71.54

ml/min/173m2

0.76

221

(40760892) CBC W Ordered Manual Differential panel - Blood

548

4625

1.36

5.87

7.2

8.2

—

(3019060) Gas panel - Arterial blood

374

1.89

5.64

5.0

6.2

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

237

2.11

5.50

1.5

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

231

2.12

5.46

1.2

1.3

—

7.74

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

291

2240

1.40

5.44

2.9

2.7

3.02

2.84

mg/l

0.71

258

1966

(40767503) Oxygen content in Capillary blood by calculation

162

2.32

5.28

3.0

17.75

16.88

0.76

(3001604) Monocytes [#/volume] in Blood

571

4903

1.33

5.21

6.8

7.6

0.59

0.57

e9/l

0.98

495

4182

(3019198) Lymphocytes [#/volume] in Blood

585

5055

1.33

5.04

6.7

7.6

1.93

2.13

e9/l

2.70

517

4427

(3034426) Prothrombin time (PT)

4.72

4.98

1.1

1.3

—

(3006315) Basophils [#/volume] in Blood

569

4905

1.32

4.95

6.8

7.6

0.04

e9/l

1.10

494

4180

(3013115) Eosinophils [#/volume] in Blood

585

5066

1.32

4.91

7.2

8.2

0.18

0.20

e9/l

1.63

516

4402

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

150

2.30

4.80

1.3

1.5

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

244

2.00

4.76

1.6

2.2

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

154

2.24

4.53

1.5

1.3

—

(1616796) Gas panel - Central venous blood

182

2.12

4.42

5.6

4.2

—

(3019309) Folate [Moles/volume] in Red Blood Cells

155

1108

1.46

4.31

1.8

1.7

1161.55

1163.91

nmol/l

0.01

112

835

(3000012) Reticulocyte production index

2.67

4.31

1.8

2.4

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

198

2.05

4.28

2.1

2.5

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

269

1.89

4.24

1.9

2.0

—

(3020630) Protein [Mass/volume] in Serum or Plasma

544

1.62

4.17

1.8

3.1

65.85

66.31

g/l

0.18

508

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

351

2887

1.31

4.08

4.0

34.48

32.36

u/l

0.18

328

2764

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

149

1074

1.44

3.97

5.2

5.3

9.96

7.36

umol/l

0.63

134

901

(3021901) Oxygen saturation in Capillary blood

170

2.09

3.96

5.0

5.4

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

3.04

3.95

1.4

1.2

75.10

89.67

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

687

6183

1.28

3.87

8.0

6.8

92.72

92.79

u/l

0.01

652

5818

(3042631) Mycobacterium sp identified in Specimen

2.58

3.87

2.1

3.8

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

2.52

3.87

2.1

2.3

32.45

32.16

0.11

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

104

701

1.53

3.86

3.2

3.1

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

453

1.65

3.84

1.6

1.4

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

2.98

3.83

1.3

1.1

84.10

94.56

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

447

1.65

3.78

1.9

1.7

—

(3022096) Basophils/100 leukocytes in Blood

521

4548

1.27

3.71

7.2

7.8

0.62

0.66

1.22

497

4317

(3001122) Ferritin [Mass/volume] in Serum or Plasma

492

4280

1.26

3.56

3.8

3.0

99.06

89.69

ug/l

0.47

458

4016

(3019069) Monocytes/100 leukocytes in Blood

536

4712

1.26

3.54

7.4

8.0

8.63

8.35

1.34

513

4483

(3013707) Erythrocyte sedimentation rate by Westergren method

702

6370

1.27

3.53

4.6

4.2

10.56

10.21

mm/h

0.34

671

5927

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

294

2405

1.30

3.48

3.0

2.6

63.73

57.42

u/l

0.84

273

2228

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

2.90

3.45

1.2

1.1

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

252

1.81

3.42

1.4

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

245

1.82

3.41

1.8

—

(3018418) pH of Serum or Plasma

274

2228

1.30

3.39

4.5

3.9

7.40

0.19

407

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

283

1.76

3.37

1.5

2.2

—

(3002030) Lymphocytes/100 leukocytes in Blood

551

4879

1.25

3.35

7.2

7.7

28.84

31.89

7.65

528

4659

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

114

808

1.45

3.33

7.1

5.7

—

(3006504) Eosinophils/100 leukocytes in Blood

531

4684

1.25

3.33

7.2

7.7

2.84

3.01

0.93

507

4451

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

289

1.72

3.15

1.5

2.0

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

201

1.86

3.11

1.4

1.9

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

615

5545

1.24

3.06

9.5

10.2

3.93

3.81

e9/l

0.71

543

4759

(3021589) Normoblasts [#/volume] in Blood

512

4530

1.24

3.03

9.9

10.4

0.00

e9/l

0.06

406

3600

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

220

1.79

2.93

1.7

2.0

—

(3018010) Neutrophils/100 leukocytes in Blood

540

4816

1.23

2.93

6.9

7.5

55.99

53.13

5.94

517

4592

(3049717) Cytology report of Urine Cyto stain

177

1.88

2.90

2.7

2.6

—

(21494755) Public health laboratory ask at order entry panel

933

0.65

2.77

1.3

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

110

2.11

2.77

1.3

1.8

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

568

1.47

2.73

3.3

3.2

4.62

4.77

pmol/l

0.49

513

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

4.67

2.59

1.1

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

755

7019

1.23

2.56

4.6

3.9

14.82

14.57

pmol/l

1.93

697

6472

(3051593) INR in Capillary blood by Coagulation assay

4.01

2.56

1.1

12.6

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

4.01

2.56

1.1

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

156

1.88

2.56

1.7

1.4

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

121

2.00

2.54

1.5

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

403

0.51

2.50

1.0

1.2

3.56

3.23

u/ml

0.04

283

(3026250) Tacrolimus [Mass/volume] in Blood

2.28

2.49

43.7

45.2

6.64

6.50

ug/l

0.12

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

529

1.46

2.49

1.7

—

(3021960) Folate [Moles/volume] in Serum or Plasma

197

1595

1.28

2.48

1.7

1.4

18.98

21.44

nmol/l

1.59

176

1375

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

165

1.83

2.48

1.5

1.6

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

2.18

2.40

1.4

1.7

—

(3035880) pH of Pleural fluid

3.34

2.38

1.2

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

3.34

2.38

1.3

1.8

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

408

0.53

2.36

1.0

1.2

1.53

1.11

u/ml

0.12

276

(3021788) Differential panel - Synovial fluid

111

1.99

2.34

2.0

1.7

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

125

1.93

2.34

1.3

1.7

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

308

2644

1.22

2.31

2.7

3.2

2.36

2.37

mmol/l

0.65

266

2389

(3037522) Nuclear Ab [Titer] in Serum

156

1238

1.30

2.30

1.5

1.4

590.00

498.71

titre

0.28

248

(3003888) Timothy IgE Ab [Units/volume] in Serum

417

0.54

2.30

1.0

1.2

2.73

5.09

u/ml

0.54

301

(3000494) Fungus identified in Specimen by Culture

126

972

1.33

2.28

1.7

1.5

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

3.48

2.26

1.0

1.1

—

(3009871) Measles virus Ab [Titer] in Serum

2.86

2.20

1.5

1.9

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

182

1.72

2.11

1.5

1.9

—

(3007853) Bacteria identified in Skin by Aerobe culture

139

1101

1.30

2.09

2.3

1.6

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

453

0.58

2.07

1.1

1.2

7.41

3.33

u/ml

0.37

316

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

189

1558

1.25

2.06

3.0

1.17

0.97

e6/l

0.29

113

862

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

139

1.81

2.04

1.9

1.5

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

2.18

2.03

1.1

1.8

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

154

1.77

2.03

1.4

24.97

20.11

u/l

0.28

131

(3000850) Epithelial cells [#/volume] in Urine

221

1862

1.23

1.97

3.4

2.8

5.56

6.77

e6/l

0.65

206

1649

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

768

7229

1.19

1.96

15.7

10.5

87.83

88.22

ml/min/173m2

0.16

659

5681

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

226

1.61

1.93

1.6

2.0

—

(3025941) Bacteria identified in Stool by Culture

489

1.41

1.93

1.3

1.2

—

(3026361) Erythrocytes [#/volume] in Blood

1056

10308

1.48

1.92

25.9

18.4

4.48

4.53

e12/l

2.38

1037

9942

(3026493) Urate [Moles/volume] in Serum or Plasma

219

1849

1.22

1.92

3.7

3.1

3600.06

5294.03

umol/l

0.21

197

1651

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

120

1.84

1.91

1.1

1.5

—

(3010813) Leukocytes [#/volume] in Blood

1056

10309

1.48

1.91

25.9

18.4

6.78

e9/l

0.03

1038

9942

(3018095) Leukocytes [#/volume] in Urine

369

3274

1.18

1.90

4.8

4.2

33.28

93.92

e6/l

3.01

266

2225

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

715

1.34

1.90

6.2

6.0

80.16

65.39

ng/l

1.59

670

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

424

1.43

1.88

1.6

1.8

—

(3000963) Hemoglobin [Mass/volume] in Blood

1056

10312

1.47

1.87

26.8

18.6

132.62

134.18

g/l

2.84

1051

10187

(3007461) Platelets [#/volume] in Blood

1055

10301

1.46

1.86

26.0

18.5

250.01

261.79

e9/l

6.87

1039

9965

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

133

1631

0.79

1.85

2.2

2.3

—

(40768804) Tissue Pathology biopsy report

347

3072

1.18

1.82

2.0

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

233

0.47

1.80

1.0

1.1

0.02

0.49

u/ml

—

117

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

3.05

1.79

1.0

—

(3037467) Urinalysis macro (dipstick) panel - Urine

646

6018

1.17

1.78

4.8

4.2

—

(3005322) IgE [Units/volume] in Serum or Plasma

106

829

1.30

1.78

1.2

1.4

193.92

275.85

u/ml

0.70

771

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

857

8173

1.20

1.77

5.3

4.5

1.96

2.03

mu/l

0.21

806

7619

(3009542) Hematocrit [Volume Fraction] of Blood

1054

10297

1.44

1.77

27.5

18.8

39.44

39.91

1.86

1013

9785

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

576

1.36

1.75

4.7

4.5

1.23

mmol/l

0.07

501

(3020911) Cortisol [Moles/time] in 24 hour Urine

2.67

1.72

2.3

1.5

69.35

87.33

nmol/24h

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

2.67

1.72

1.8

4.4

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

242

1.54

1.70

2.2

1.9

3.02

4.69

iu/l

0.95

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

226

1.56

1.70

1.7

2.0

—

(3019225) pH of Specimen

632

1.33

1.69

5.3

4.2

—

(3050129) First trimester maternal screen panel - Serum or Plasma

437

0.63

1.65

1.5

1.4

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

339

0.58

1.64

1.5

1.4

—

(3004616) Nuclear Ab [Presence] in Serum

1.90

1.64

1.5

1.3

—

(4200892) Spirometry reversibility

548

1.35

1.63

1.6

1.5

—

(3032057) Clostridioides difficile [Presence] in Stool

3.57

1.61

2.6

2.1

—

(3026008) Bacteria identified in Urine by Culture

281

2469

1.18

1.60

3.2

2.8

—

(3030467) Casts [#/volume] in Urine by Automated count

288

2536

1.18

1.60

4.0

3.5

0.42

0.35

e6/l

0.32

232

1886

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

2.50

1.59

1.5

1.9

—

(3002179) Metamyelocytes/100 leukocytes in Blood

612

1.33

1.59

3.8

4.6

0.77

0.55

0.51

209

(3014133) Dog dander IgE Ab [Units/volume] in Serum

271

0.55

1.56

1.1

1.95

7.85

u/ml

—

166

(3023183) Ammonium ion [Moles/volume] in Plasma

264

1.49

1.55

2.9

4.0

29.72

36.04

umol/l

1.87

244

(3002385) Erythrocyte distribution width [Ratio]

876

8402

1.19

1.54

21.0

16.0

14.52

14.25

0.83

866

8281

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

2.11

1.54

1.2

1.1

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

145

1.66

1.53

7.4

4.9

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

122

1477

0.80

1.53

2.1

2.2

—

(3021440) Promyelocytes/100 leukocytes in Blood

626

1.31

1.51

4.6

5.0

0.21

0.12

0.33

204

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

895

0.75

1.50

1.7

1.8

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

102

814

1.27

1.49

4.5

3.9

33.41

31.85

0.81

578

(3025159) Blasts/100 leukocytes in Blood

602

1.31

1.47

4.7

5.1

0.12

0.07

0.24

177

(3017181) Myelocytes/100 leukocytes in Blood

664

1.30

1.47

4.6

4.9

1.23

0.94

0.38

242

(3026782) Osmolality of Urine

211

1822

1.19

1.47

4.0

3.0

572.63

556.90

mosm/kgh2o

0.43

197

1565

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

318

2845

1.16

1.43

2.2

1.8

96.51

96.86

pmol/l

0.05

193

1460

(40757373) Influenza virus identified in Isolate

3.12

1.43

1.4

1.3

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

3.12

1.43

6.4

14.4

—

(3033799) Differential panel - Peritoneal fluid

3.12

1.43

1.6

1.7

—

(3031040) Bacteria [#/volume] in Urine by Automated count

610

5713

1.14

1.42

4.8

4.1

11.20

2704.81

e6/l

—

(3004588) Protein electrophoresis panel - Serum or Plasma

388

1.38

1.41

1.4

2.3

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

249

0.55

1.40

1.1

6.19

9.42

u/ml

—

136

(3033705) Calcium.ionized [Moles/volume] in Venous blood

1.86

1.39

4.4

2.5

—

(3036180) Methadone [Presence] in Urine

1.90

1.38

1.6

1.7

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

2.20

1.36

1.2

1.8

—

(42529406) Shigella sp [Presence] in Stool by Culture

289

1.43

1.36

1.2

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

2.94

1.35

1.6

1.1

—

(3002582) Erythrocytes [#/volume] in Urine

308

2760

1.16

1.35

4.2

3.6

50.97

67.91

e6/l

0.23

252

2085

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

281

1.43

1.35

1.1

1.2

—

(3042733) HLA Ab [Presence] in Serum

2.13

1.33

5.6

2.6

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

2.13

1.33

1.2

1.7

—

(3002256) Pathology report gross observation

112

919

1.24

1.32

1.1

1.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

283

1.42

1.31

1.1

1.2

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

2.09

1.30

1.2

1.7

—

(40768797) Stomach Pathology biopsy report

128

1069

1.22

1.28

1.3

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

2.78

1.28

1.6

1.4

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

177

1525

1.19

1.27

3.3

3.66

2.56

e6/l

0.63

103

839

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

421

0.68

1.27

1.4

1.8

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

187

1.50

1.23

1.6

2.0

—

(40758558) Short blood count panel - Blood

299

2694

1.15

1.21

7.5

8.2

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

332

1.37

1.18

1.5

1.4

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

2.31

1.18

2.2

1.2

—

(3000093) Morphology [Interpretation] in Blood Narrative

1.71

1.16

1.1

1.2

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

133

1.58

1.16

1.1

—

(36304419) Bacteria [Presence] in Urine

279

2511

1.14

1.15

4.0

3.4

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

164

1418

1.18

1.14

1.5

1.6

454.02

40565690.23

pmol/l

1.93

141

1203

(3023511) Choriogonadotropin [Units/volume] in Urine

300

1.38

1.14

1.4

1.3

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

2.00

1.11

1.4

1.3

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

2.00

1.11

1.4

1.3

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

2.00

1.11

1.4

1.3

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

2.26

1.10

1.6

1.9

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

2.26

1.10

1.6

1.9

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

180

0.55

1.08

1.6

—

(3017732) Neutrophils [#/volume] in Blood

595

1.26

1.07

2.4

2.5

5.52

6.58

e9/l

0.24

532

(3034274) Bile acid [Moles/volume] in Serum --fasting

244

1.40

1.07

5.0

4.3

10.44

12.07

umol/l

0.17

201

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

1.76

1.06

1.5

1.7

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

1.76

1.06

1.5

1.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

1.76

1.06

1.5

1.7

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

607

1.25

1.04

2.6

4.1

5.67

26.98

ug/l

0.91

487

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

187

1.45

1.03

1.7

2.0

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

1.89

1.00

1.1

302.88

233.17

iu/ml

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

788

7586

1.12

0.98

4.3

3.8

5.72

5.76

mmol/l

0.48

732

6985

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

1.71

0.98

1.1

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.00

0.98

0.0

1.1

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

0.00

0.98

0.0

1.2

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

292

1.34

0.97

1.5

1.8

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

249

1.37

0.97

2.0

3.2

50.23

879.58

u/ml

0.85

214

(1761482) Bacteria [#/volume] in Urine by Culture

173

1.45

0.96

6.0

4.0

—

(3051651) Icteric interference index of Serum or Plasma

1.63

0.96

4.4

4.1

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

124

1.54

0.96

1.7

1.8

—

(3041672) Baker's yeast Ab [Presence] in Serum

0.00

0.95

0.0

1.2

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

2.22

0.93

2.3

—

(3000475) Leukocytes [#/volume] in Synovial fluid

151

1.46

0.89

2.0

1.7

21316.06

16959.10

e6/l

0.20

115

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

1.75

0.89

2.5

3.4

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

2.07

0.89

2.0

2.2

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

105

0.47

0.88

1.0

3.9

24.30

22.77

ug/l

—

105

(3052851) Hemolysis interference index of Serum or Plasma

271

1.33

0.88

2.8

3.1

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

1.86

0.87

1.6

1.8

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

1.86

0.87

1.6

1.8

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

203

1.38

0.86

1.5

1.4

82.16

162.60

pmol/l

0.70

197

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

186

1.40

0.86

4.2

60.12

54.28

1.01

186

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.82

0.85

1.1

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

815

0.82

0.84

1.1

—

(40761535) Cells panel - Urine sediment

570

1.22

0.83

3.3

3.6

—

(3035933) Granulocytes/100 leukocytes in Blood

115

0.52

0.82

1.5

1.4

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

154

1.43

0.82

1.1

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

1.87

0.81

2.0

1.2

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

660

0.81

1.5

—

(3020891) Body temperature

258

1.32

0.80

4.5

5.5

—

(3019832) Treponema pallidum Ab [Presence] in Serum

110

1256

0.86

0.80

1.5

1.7

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

0.00

0.79

0.0

4.2

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

0.00

0.79

0.0

2.1

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

0.00

0.78

0.0

3.0

—

(3047189) Immunofixation for 24 hour Urine

0.00

0.78

0.0

2.0

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

0.00

0.78

0.0

3.0

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

728

7022

1.10

0.76

5.2

4.9

38.23

38.76

mmol/mol

0.85

689

6587

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

2.17

0.76

3.0

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

2.17

0.76

2.4

2.0

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

587

5614

1.09

0.73

3.9

3.6

50.65

41.44

u/l

1.72

558

5318

(40768446) Kidney Pathology biopsy report

1.64

0.73

2.0

2.4

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

2.00

0.72

2.0

1.2

10.20

9.01

ug/l

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

1.79

0.72

1.1

1.5

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

1.79

0.72

1.6

1.2

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

1.79

0.72

1.6

1.2

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

1.61

0.72

1.1

1.2

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

747

1.17

0.71

1.2

149.47

143.34

iu/ml

0.04

286

(4146454) Self-monitoring of blood glucose

1.67

0.71

3.7

2.9

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

372

1.24

0.69

2.6

2.5

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

1.71

0.69

1.1

1.2

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

1.71

0.69

1.1

1.2

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

1.55

0.69

1.1

2.0

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

949

9293

1.13

0.68

11.4

9.8

25.64

26.15

u/l

0.27

927

9008

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

1.66

0.68

2.6

2.5

51328.57

38388.21

ug/l

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.56

0.68

1.3

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

1.59

0.67

1.7

1.4

1.52

1.38

promille

0.15

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

1.63

0.66

1.1

1.2

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

153

1.37

0.66

1.9

1.7

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.59

0.65

1.1

1.2

—

(4281824) Cell count and differential, peritoneal fluid

1.61

0.64

1.2

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

1.61

0.64

1.0

1.5

—

(3025130) Human papilloma virus identified in Specimen

127

0.63

0.64

1.5

1.6

—

(3026389) Candida sp identified in Specimen by Organism specific culture

103

1.46

0.64

1.1

1.2

—

(21494814) CD8 cells/100 lymphocytes in Specimen

1.72

0.63

3.0

2.6

—

(3002079) Sodium [Moles/time] in 24 hour Urine

1.72

0.63

1.0

1.1

197.80

175.78

mmol/24h

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

113

1002

1.14

0.62

3.4

2.6

341.05

349.63

nmol/l

0.14

104

944

(3048929) Epstein Barr virus Ab [Presence] in Serum

595

0.83

0.62

1.8

1.7

—

(3041096) Erythrocytes [Presence] in Urine by Automated

215

2313

0.91

0.62

4.2

3.1

—

(3005011) Chlamydia sp Ab [Titer] in Serum

1.66

0.61

1.2

1.3

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

377

0.79

0.61

1.5

1.3

198.76

233.49

miu/ml

0.28

181

(3044927) Protein electrophoresis panel - Urine

1.59

0.61

1.4

1.1

—

(4034850) Laboratory test

244

1.27

0.60

15.0

7.9

—

(3045414) Leukocytes [Presence] in Urine

371

1.22

0.59

2.1

1.9

—

(40758292) HTLV I+II Ab panel - Serum

0.00

0.58

0.0

1.3

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

1.51

0.58

1.5

1.3

—

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

1.71

0.57

2.0

1.7

1.56

0.91

mg/l

—

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

1.71

0.57

2.0

1.7

1.74

2.90

mg/l

—

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

1.71

0.57

2.0

1.7

2.25

1.46

mg/l

—

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

1.71

0.57

2.0

1.7

1.00

1.28

mg/l

—

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

1.71

0.57

2.0

1.7

0.94

1.20

mg/l

—

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

1.71

0.57

2.0

1.7

0.29

0.84

mg/l

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

1.71

0.57

2.0

1.7

0.14

1.13

mg/l

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

1.71

0.57

2.0

1.2

—

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

1.71

0.57

2.0

1.7

1.75

5.23

mg/l

—

(3045424) Erythrocytes [Presence] in Urine

140

1.36

0.57

1.7

1.5

—

(3020874) Milk IgE Ab [Units/volume] in Serum

195

0.71

0.57

1.0

1.5

1.83

4.11

u/ml

—

130

(3037756) Immunofixation for Serum or Plasma

106

1.42

0.57

1.1

1.8

—

(3049233) Organic acids panel - Urine

1.66

0.56

1.3

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

132

1.36

0.56

1.1

1.0

1.49

1.43

g/l

0.26

122

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

167

1.32

0.56

2.4

3.5

—

(3029075) Extractable nuclear Ab panel - Serum

1.45

0.56

1.0

1.2

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

1.45

0.56

1.3

1.4

78.62

71.91

umol/l

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

1.47

0.53

4.6

5.3

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

1.47

0.53

1.4

1.2

—

51.00

—

(3044941) Cell count panel - Synovial fluid

1.41

0.53

1.6

1.5

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

191

0.73

0.52

1.1

1.5

10.48

12.15

u/ml

—

122

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

1.51

0.52

1.1

1.6

—

(3022670) pH of Venous cord blood

1.50

0.51

1.0

—

(3000330) Specific gravity of Urine by Test strip

369

1.20

0.51

4.0

3.2

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

260

1.23

0.50

1.4

298.69

323.77

ug/g

0.30

148

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

1.41

0.50

1.2

1.1

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

155

0.70

0.49

1.0

1.1

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

154

1414

1.10

0.49

1.3

14.84

29.85

iu/ml

5.17

429

(3011397) Hemoglobin [Presence] in Urine by Test strip

230

2152

1.08

0.48

3.4

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

244

0.77

0.48

4.7

2.0

0.84

0.70

nmol/l

0.27

207

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

1.49

0.47

5.0

4.0

83.03

148.58

ug/l

—

(3051611) Lipemic interference index of Serum or Plasma

111

1.35

0.46

4.4

3.7

—

(3030905) Polymorphonuclear cells [#/volume] in Blood

182

1.26

0.45

3.7

4.97

3.90

e9/l

0.99

182

(3023419) Bacteria identified in Sputum by Culture

1.38

0.45

1.5

4.2

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

273

1.21

0.45

5.7

4.2

25.70

22.14

nmol/l

0.57

268

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

152

0.72

0.45

1.3

1.2

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

152

0.72

0.45

1.0

1.2

1.18

2.73

u/ml

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.40

0.45

6.6

8.5

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

237

1.23

0.44

11.6

9.6

182.40

314.09

iu/ml

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

328

0.82

0.44

1.5

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

328

0.82

0.44

1.5

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

328

0.82

0.44

1.5

1.4

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

112

1.34

0.44

1.1

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

327

0.82

0.43

1.5

1.4

—

(3035637) Corticotropin [Mass/volume] in Plasma

247

1.22

0.43

1.8

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

162

0.74

0.43

1.2

1.3

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

792

7746

1.07

0.43

4.3

4.0

4.46

4.68

mmol/l

8.03

753

7289

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

136

1252

1.09

0.42

2.5

2.7

2.41

2.44

mmol/l

1.88

110

1085

(3020393) Adenovirus Ag [Presence] in Stool

104

1.35

0.42

1.3

2.1

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

369

0.83

0.42

1.5

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

1.56

0.42

1.4

1.0

—

(3020682) Albumin/Creatinine [Ratio] in Urine

204

1912

1.08

0.42

4.1

3.8

8.01

17.45

mg/mmol

0.50

137

1227

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

113

1.33

0.42

1.3

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

1.38

0.41

1.0

—

(3009410) PHENobarbital [Moles/volume] in Serum or Plasma

0.00

0.41

0.0

11.6

—

96.13

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

0.00

0.41

0.0

1.3

—

8.28

—

(3013247) Albumin in CSF/Albumin in Serum or Plasma

1.51

0.41

1.0

1.1

4.57

5.48

mg/g

—

(3024263) Appearance of Synovial fluid

1.51

0.41

1.4

1.6

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

0.00

0.41

0.0

1.3

—

(3016750) Collection duration of Urine

1.47

0.40

3.4

2.3

536.00

516.88

min

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

114

1.32

0.40

1.1

1.4

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

296

1.18

0.39

1.3

1.5

—

(3000492) Spirometry study

825

1.11

0.39

1.7

1.4

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

161

1714

0.93

0.39

1.7

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

105

0.66

0.39

1.1

1.3

6.52

3.15

u/ml

—

100

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

1.43

0.39

1.2

1.1

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

376

0.84

0.39

1.5

1.6

6.40

3.45

mg/l

0.41

272

(3012516) Albumin [Mass/volume] in Urine

195

1832

1.07

0.38

3.5

3.3

329.50

235.83

mg/l

0.12

134

1210

(3022621) pH of Urine by Test strip

513

0.87

0.38

2.6

2.5

—

(3007164) IgA [Mass/volume] in Serum or Plasma

275

2615

1.06

0.38

1.5

1.6

1.93

1.97

g/l

0.15

169

1447

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

1.39

0.38

1.2

1.5

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

392

1.15

0.36

1.5

1.3

—

(4035726) Immunohistochemistry procedure

667

1.11

0.36

1.4

1.5

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

211

0.80

0.35

1.5

1.8

—

(3004959) Base excess in Arterial cord blood by calculation

211

0.80

0.35

1.0

-2.95

-2.01

mmol/l

—

(3006598) pH of Arterial cord blood

211

0.80

0.35

1.0

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

319

1.16

0.35

1.9

2.1

35.70

40.28

u/l

0.92

292

(3008898) HLA-B27 [Presence]

403

0.86

0.34

1.1

—

(40768793) Breast Pathology biopsy report

188

0.79

0.34

1.6

1.3

—

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

1.37

0.34

1.2

78.20

80.84

—

(3016879) Cocaine [Presence] in Urine

549

0.88

0.33

1.8

1.9

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

1.34

0.33

1.0

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

1.32

0.33

1.1

—

(40765089) Chromosome analysis panel - Blood by G-banded

0.69

0.33

1.2

1.0

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

0.68

0.33

1.2

1.3

—

(4094501) Cardiovascular stress test using bicycle ergometer

176

0.79

0.33

1.1

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

118

1.27

0.33

1.1

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

219

0.82

0.32

1.0

1.1

1.48

5.00

u/ml

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

262

0.83

0.32

1.4

1.5

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

1.27

0.32

2.0

5.0

—

(3037121) Protein [Mass/volume] in Urine

397

1.13

0.32

5.5

6.1

0.22

0.36

g/l

1.00

245

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

1.35

0.31

1.2

1.1

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

142

0.77

0.31

2.5

1.7

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

271

0.84

0.30

2.0

3.0

1.47

5.13

e6/l

2.45

202

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

271

0.84

0.30

2.0

3.0

33.89

256.16

e6/l

1.90

208

(3047007) Chlamydophila sp Ab [Presence] in Serum

230

1.17

0.30

1.1

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

796

7821

1.05

0.30

4.7

4.3

2.65

2.80

mmol/l

4.80

751

7312

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

1.27

0.30

1.0

1.2

—

(3027944) Amphetamines [Presence] in Urine

585

0.90

0.29

1.8

1.9

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

1.33

0.29

1.2

1.1

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

120

1.25

0.29

1.5

1.3

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

111

1.26

0.29

7.1

4.6

22.71

26.29

umol/l

1.37

111

(1002224) Polysomnography panel

353

1.13

0.29

1.0

1.1

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

298

2865

1.05

0.29

1.4

1.6

0.71

2.99

u/ml

6.50

638

(44816559) Phosphatidylethanol [Mass/volume] in Blood

194

1.19

0.28

1.8

1.2

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

1.29

0.28

2.4

2.1

—

(40768795) Lymph node Pathology biopsy report

1.29

0.28

1.0

1.1

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

312

3211

0.96

0.27

4.2

3.5

—

(3023410) Appearance of Cerebral spinal fluid

171

0.81

0.27

2.4

3.9

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

743

7300

1.04

0.26

3.5

3.6

—

(3001019) Free T4 and TSH panel - Serum or Plasma

480

1.11

0.26

1.7

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

730

1.08

0.26

1.5

1.4

—

(3015736) pH of Urine

366

3545

1.04

0.26

3.5

3.3

5.97

6.02

0.12

348

(3004716) Salmonella sp identified in Stool by Organism specific culture

596

1.09

0.25

1.2

1.3

—

(40768800) Prostate Pathology biopsy report

1.21

0.25

1.1

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

751

7384

1.04

0.25

4.0

3.6

1.20

1.25

mmol/l

1.53

708

6895

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

1.20

0.25

2.1

1.4

—

(3011288) Drugs identified in Urine by Screen method

401

0.89

0.24

2.7

2.3

—

(3016018) Differential panel - Cerebral spinal fluid

147

0.81

0.24

2.4

3.0

—

(3039443) Prostate specific Ag panel - Serum or Plasma

125

0.80

0.23

2.1

1.7

—

(3003740) Influenza virus B Ag [Presence] in Specimen

265

1.13

0.23

1.2

—

(3004775) Volume in Urine collected for unspecified duration

1.28

0.23

3.4

2.4

743.00

615.28

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

117

1105

1.06

0.22

1.6

1.47

1.43

0.19

109

992

(3025468) Yersinia sp identified in Specimen by Organism specific culture

0.77

0.22

1.6

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

0.77

0.22

1.6

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

0.76

0.22

1.6

1.4

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

0.75

0.22

1.6

1.3

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

0.75

0.22

1.6

1.4

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

0.74

0.22

1.6

1.4

—

(36660697) Celiac disease serology panel - Serum

109

1147

0.94

0.22

1.2

—

(3002523) Influenza virus A Ag [Presence] in Specimen

266

1.13

0.22

1.2

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

203

2098

0.96

0.22

1.9

2.0

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

216

2078

1.04

0.21

1.5

1.7

1.37

1.38

mmol/l

0.03

183

1801

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

0.00

0.21

0.0

1.3

—

(3028717) Thiamine [Mass/volume] in Blood

0.00

0.21

0.0

1.5

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

0.00

0.21

0.0

1.3

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

0.21

0.0

1.0

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

0.00

0.21

0.0

2.8

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

0.00

0.21

0.0

1.0

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

314

1.11

0.21

2.1

2.0

—

(1761868) Lipid panel - Serum or Plasma

280

2872

0.96

0.21

2.4

2.5

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

261

0.88

0.21

1.6

1.4

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

0.00

0.21

0.0

1.0

—

(3013293) Extractable nuclear Ab [Presence] in Serum

0.00

0.21

0.0

1.7

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

1.16

0.21

1.4

1.3

—

53.33

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

0.00

0.21

0.0

1.2

—

(3005033) Fetal Nuchal fold Thickness US

260

0.88

0.20

1.5

1.4

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

990

0.94

0.20

1.9

2.0

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

0.00

0.20

0.0

2.0

—

2.54

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

0.00

0.20

0.0

1.1

—

(3001556) Androgen free Index in Serum or Plasma

0.00

0.20

0.0

1.1

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

1.20

0.19

1.0

1.2

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

144

1376

1.05

0.19

1.3

1.2

9.29

9.49

u/ml

0.01

518

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

780

7695

1.03

0.19

4.3

3.9

1.43

1.47

mmol/l

2.37

738

7204

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

1.22

0.18

1.3

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

1.22

0.18

1.3

1.2

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

1.22

0.18

1.3

1.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

1.22

0.18

1.3

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

1.22

0.18

1.3

1.2

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

811

1.06

0.18

1.6

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

268

0.89

0.18

1.5

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

109

1.19

0.18

1.8

2.1

—

(3015183) Erythrocyte sedimentation rate

1.18

0.18

1.1

1.2

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

395

1.09

0.18

1.4

1.3

—

(3044290) Cell count panel - Cerebral spinal fluid

257

0.89

0.17

1.8

3.1

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

128

1.17

0.17

1.5

1.3

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

1.21

0.17

1.3

1.2

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

141

0.85

0.17

1.0

1.3

3.93

24.63

u/ml

—

112

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

1.17

0.16

1.1

1.6

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

253

1.11

0.16

1.6

1.4

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

253

1.11

0.16

1.6

1.4

—

(3000764) Benzodiazepines [Presence] in Urine

584

0.94

0.16

1.7

1.9

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.11

0.16

1.0

1.3

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

1.19

0.15

1.2

1.1

183.00

222.88

mg/l

0.62

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

554

1.06

0.15

2.2

2.3

10344.75

4391.71

u/l

0.48

211

(3035320) C reactive protein [Mass/volume] in Body fluid

1.09

0.15

3.2

1.9

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

1.09

0.15

1.7

1.6

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.09

0.15

1.1

1.2

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

815

0.95

0.14

1.8

1.9

—

(40760888) Immunoglobulin light chains.free panel - Serum

128

0.85

0.14

1.4

4.2

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

112

1.16

0.14

1.0

1.1

—

(3019150) Specific gravity of Urine by Refractometry

188

1924

0.97

0.14

4.2

3.6

1.01

1.02

kg/l

0.70

295

(3028300) Cannabinoids [Presence] in Urine

590

0.94

0.13

1.9

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

141

1361

1.04

0.13

4.1

1.63

2.16

ug/l

1.04

120

1245

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

162

1661

0.97

0.13

1.8

1.7

—

(3035350) Ketones [Presence] in Urine by Test strip

439

4313

1.02

0.13

4.1

3.5

0.00

estimate

0.50

837

(3014148) Varicella zoster virus Ab [Titer] in Serum

189

1.11

0.13

1.2

—

(3027008) Opiates [Presence] in Urine

588

0.95

0.12

1.7

1.9

—

(3009508) Creatinine [Moles/volume] in Urine

248

2421

1.03

0.12

3.7

7.66

7.78

mmol/l

0.15

215

2129

(3048689) Calprotectin [Mass/mass] in Stool

142

1457

0.97

0.12

2.0

2.9

117.73

101.61

ug/g

0.26

105

1176

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

1.17

0.12

1.3

1.1

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

229

1.09

0.11

1.3

1.2

3.52

5.65

u/ml

—

(4062490) Immunoglobulin typing, IgG

136

0.88

0.11

1.1

1.3

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

162

1.11

0.11

1.1

1.2

—

(40768441) Liver Pathology biopsy report

1.16

0.11

1.8

1.7

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

564

0.95

0.10

1.2

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

182

1.10

0.10

2.0

1.4

0.75

0.33

nmol/l

0.34

148

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

330

0.93

0.10

1.5

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

166

0.90

0.10

1.4

1.3

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

309

0.93

0.10

1.6

1.7

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

241

1.08

0.09

1.0

1.1

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

461

0.95

0.09

1.9

1.8

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

1.08

0.09

2.8

2.7

—

(40761536) Microorganisms panel - Urine sediment

721

1.04

0.09

4.9

3.8

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

572

0.96

0.09

1.2

1.3

15.28

38.11

au/ml

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

496

1.05

0.09

2.0

1.9

9.14

7.83

u/l

0.32

330

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

1.09

0.08

1.2

1.5

—

(3013336) Amino acids [Identifier] in Serum or Plasma

1.07

0.08

1.3

2.4

—

(3020491) Glucose [Moles/volume] in Blood

0.78

0.08

2.8

1.6

5.38

6.11

mmol/l

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

630

0.96

0.08

1.8

1.7

17.43

20.33

iu/l

0.35

476

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

146

1.09

0.07

1.0

1.1

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

0.84

0.07

1.0

—

(3029937) Albumin [Presence] in Urine by Test strip

228

2239

1.02

0.07

4.2

3.8

0.00

estimate

1.08

789

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

152

1543

0.98

0.07

1.4

—

(40768443) Skin Pathology biopsy report

283

1.06

0.07

1.2

—

(3027901) Hemoglobin [Mass/volume] in Arterial cord blood

1.12

0.07

1.0

164.27

162.31

g/l

0.12

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

789

0.97

0.07

2.6

2.7

0.84

0.69

ug/l

0.25

451

(3017446) Testosterone [Moles/volume] in Serum or Plasma

608

1.03

0.07

2.2

8.90

11.32

nmol/l

1.30

555

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

1.04

0.07

1.2

3.2

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

1.04

0.07

1.2

3.2

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

0.86

0.06

1.9

1.4

387.25

494.59

pmol/l

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

147

1.09

0.06

1.8

4.7

—

(3014051) Protein [Presence] in Urine by Test strip

213

0.93

0.06

2.9

2.5

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

354

0.96

0.06

1.7

1.9

281.52

195.46

u/ml

0.79

174

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

364

0.96

0.06

1.7

1.9

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

374

3698

1.01

0.05

3.1

2.8

74.92

74.13

nmol/l

0.22

337

3399

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

110

0.91

0.05

2.6

1.9

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

139

1.08

0.05

3.1

2.5

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

632

1.03

0.05

2.1

2.3

12.22

18.92

au/ml

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

301

0.96

0.04

1.6

1.7

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

107

1083

0.98

0.04

3.6

3.8

22.89

21.33

0.43

441

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

119

0.92

0.04

1.9

1.4

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

209

1.05

0.04

1.3

1.9

—

(3009261) Glucose [Presence] in Urine by Test strip

435

4357

0.99

0.04

4.1

3.5

0.00

estimate

0.50

788

(3021601) Nitrite [Presence] in Urine by Test strip

431

4317

0.99

0.04

5.7

4.9

0.00

estimate

0.50

810

(3022145) Colonoscopy Study observation

853

1.02

0.03

1.4

1.3

—

(3045142) Bone marrow Pathology biopsy report

121

1.07

0.03

1.2

1.5

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

308

0.97

0.02

1.4

1.3

—

(44813793) Dust mix specific IgE antibody measurement

107

0.93

0.02

1.0

1.1

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

177

0.96

0.02

1.2

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

206

0.97

0.01

1.1

1.2

—

(3003327) Ova and parasites identified in Stool by Light microscopy

428

1.00

0.00

1.5

1.8

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

272

2714

1.00

0.00

1.9

1.8

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

135

0.96

0.00

1.2

1.1

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

119

1185

1.00

0.00

1.6

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

299

1.00

0.00

2.1

91.60

98.21

u/ml

—

(3028707) Methadone [Presence] in Urine by Screen method

285

1.01

0.00

2.2

2.1

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

212

0.99

0.00

1.2

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

565

1.01

0.00

1.4

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

412

0.99

0.00

1.3

1.2

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

792

0.99

0.00

2.7

2.3

34.77

33.02

u/l

0.13

657

(3024980) IgG subclass 4 [Mass/volume] in Serum

194

0.98

0.00

1.1

1.7

0.26

0.73

g/l

4.73

157

(3020356) Listeria sp identified in Specimen by Organism specific culture

0.00

0.0

1.0

—

(3008607) Semen analysis panel

0.00

0.0

1.2

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

0.00

0.0

1.0

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

0.00

0.0

1.0

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3023436) Glucagon [Mass/volume] in Serum or Plasma

0.00

0.0

2.2

—

178.83

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

0.98

0.00

1.0

1.1

—

(3000936) Kiwifruit IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

2.81

—

(36303722) Certolizumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

1.2

—

30.80

—

(40760409) HLA-A [Type] by High resolution

0.00

-0.00

0.0

1.0

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

0.96

-0.00

1.1

1.2

—

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

1.1

—

8.00

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

0.91

-0.00

3.4

3.0

729.80

877.44

u/ml

—

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(40763590) HLA-DQ beta [Type]

0.00

-0.00

0.0

1.0

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

0.93

-0.00

1.0

1.3

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

0.00

-0.00

0.0

1.2

—

(3051101) Glucose [Moles/volume] in Cord blood

0.00

-0.00

0.0

4.9

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

0.94

-0.00

1.0

1.2

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

1.01

-0.00

1.0

1.1

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

0.89

-0.00

1.7

3.4

50.00

55.12

—

(21494434) Karyotype in Bone marrow

0.95

-0.00

1.2

1.3

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

0.00

-0.00

0.0

1.0

—

(3024932) HLA-DR beta [Type]

0.96

-0.00

1.0

1.2

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

0.00

-0.00

0.0

3.7

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

0.00

-0.00

0.0

7.8

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.00

-0.00

0.0

1.4

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

0.00

-0.00

0.0

1.9

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.3

—

35.29

—

(3013862) HLA-DP [Type]

0.00

-0.00

0.0

1.0

—

(3000034) Microalbumin [Mass/volume] in Urine

0.95

-0.00

2.8

3.5

47.70

15.72

mg/l

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.01

-0.00

1.4

1.2

—

(3024869) Neuronal Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(40760410) HLA-B [Type] by High resolution

0.00

-0.00

0.0

1.0

—

(3041198) Albumin [Mass/volume] in Peritoneal dialysis fluid

0.00

-0.00

0.0

3.6

—

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

1.01

-0.00

1.0

2.2

7.65

3.04

nmol/l

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.6

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

0.00

-0.00

0.0

1.2

—

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

2.4

—

55.30

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

0.00

-0.00

0.0

2.4

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

-0.00

0.0

8.6

—

(46236302) HLA-C [Type] by High resolution typing

0.00

-0.00

0.0

1.0

—

(40760512) CD34 cells/100 cells in Bone marrow

0.00

-0.00

0.0

1.4

—

(3024471) HLA-A [Type]

0.95

-0.00

1.0

—

(3001729) Color of Synovial fluid

0.00

-0.00

0.0

1.4

—

(3011325) HIV 1+2 Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(40760083) Phosphate/Creatinine [Ratio] in Urine

0.00

-0.00

0.0

5.6

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

1.01

-0.00

2.3

1.7

119.38

126.72

ng/l

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.1

—

274.00

—

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: Q17_ATRIAL_SEPTAL_DEFECT_SECUNDUM_TYPE – Atrial septal defect, secundum type

GWS hits: 2

This endpoint is excluded (different definition than used in FinnGen).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Atrial septal defect, secundum type

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints